UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

————————

Form 10-Q

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March~~September 3130, 2024


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number 001-40640

PAYCOR HCM, INC.

(Exact ~~name~~Name of ~~registrant~~Registrant as ~~specified~~Specified in its ~~charter~~Charter)

Delaware									83-1813909
(State or other jurisdiction of incorporation or organization)									(I.R.S. Employer Identification No.)
(State or Other Jurisdiction of Incorporation or Organization)									(I.R.S. Employer Identification No.)
4811 Montgomery Road Cincinnati, OH									45212
(Address of Principal Executive Offices)									(Zip Code)

(800) 381-0053

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	PYCR	The NASDAQ Stock Market LLC (Nasdaq Global Select Market)

————————

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	x	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of ~~April~~October 3031, 2024, the number of shares of the ~~Registrant~~registrant’s ~~Common~~common ~~Stock~~stock outstanding was ~~178~~179,~~210~~658,~~132 shares~~817.

Table of Contents

Part I - FINANCIAL INFORMATION
Item 1. Financial Statements			5
Unaudited Condensed Consolidated Balance Sheets as of March 31, 2024 and June 30, 2023			5
Unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and June 30, 2024			5
Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2024 and 2023			6
Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2024 and 2023			6
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended March 31, 2024 and 2023			7
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended September, 2024 and 2023			7
Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended March 31, 2024 and 2023			8
Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended September 30, 2024 and 2023			8
Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2024 and 2023			10
Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2024 and 2023			9
Notes to the Unaudited Condensed Consolidated Statements			1110
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			2219
Item 3. Quantitative and Qualitative Disclosures About Market Risk			3933
Item 4. Controls and Procedures			4135
Part II - OTHER INFORMATION
Item 1. Legal Proceedings			4236
Item 1A. Risk Factors			4236
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			4236
Item 3. Defaults Upon Senior Securities			4236
Item 4. Mine Safety Disclosures			4236
Item 5. Other Information			4236
Item 6. Exhibits			4337
Signatures			4438

Table of Contents

Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q, including the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ~~(the “Securities Act”)~~, Section 21E of the Securities Exchange Act of 1934, as amended ~~(the “Exchange Act”)~~, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, our objectives for future operations, and any statements of a general economic or industry specific nature, are forward-looking statements. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” “outlook,” “potential,” “targets,” “contemplates,” or the negative or plural of these words and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe, based on information currently available to our management, may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, related to our operations, financial results, financial condition, business, prospects, growth strategy, and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. We believe that these factors include, but are not limited to:

•Our ability to manage our growth effectively.

•The resulting effects of unauthorized access to our customers’ or their employees’ personal data as a result of a breach of our or our vendors’ securities measures, including by way of computer viruses, worms, phishing and ransomware attacks, malicious software programs, and other data security threats.

•Our dependency on third-party security measures.

•The expansion and retention of our direct sales force with qualified and productive persons and the related effects on the growth of our business.

•The impact on customer expansion and retention if implementation, user experience, customer service, or performance relating to our solutions is not satisfactory.

•The timing of payments made to employees and taxing authorities relative to the timing of when a customer’s electronic funds transfers are settled to our account.

•Future acquisitions of other companies’ businesses, technologies, or customer portfolios.

•The continued service of our key executives.

•Our ability to innovate and deliver high-quality, technologically advanced products and services.

•Risks specifically associated with our development and use of artificial intelligence in our solutions.

•Our ability to attract and retain qualified personnel, including software developers and skilled IT, sales, marketing, and operation personnel.

•The proper operation of our software.

•Our relationships with third parties that provide financial and other functionality and other functionality integrated into our human capital management platform.

•Damage, failure, or disruption of our Software-as-a-Service ~~(“SaaS”)~~ delivery model, data centers, or our third-party providers’ services.

•Our ability to protect our intellectual and proprietary rights.

•The use of open source software in our applications.

•The growth of the market for cloud-based human capital management and payroll software among ~~small and medium~~mid-market ~~sized~~ businesses ~~(“SMBs”)~~.

•The competitiveness of our market generally.

•The ~~ongoing~~extent ~~effects~~to ofwhich ~~inflation,~~negative ~~supply~~macroeconomic ~~chain~~conditions ~~disruptions,~~persist ~~labor~~or ~~shortages~~worsen ~~and other adverse macroeconomic conditions~~ in the markets in which we ~~and~~or our customers operate.

•The impact of an economic downturn or recession in the United States ~~(“U.S.”)~~ or global economy.

•Our customers’ dependence on our solutions to comply with applicable laws.

•Our ability to comply with anti-corruption, anti-bribery and similar laws.

Table of Contents

•Our customers’ dependence on our solutions to comply with applicable laws.

•Our ability to comply with anti-corruption, anti-bribery and similar laws.

•Changes in laws, regulations, or requirements applicable to our software and services.

•The impact of privacy, data protection, tax and other laws and regulations.

•Our ability to maintain effective internal controls over financial reporting.

•The other risk factors set forth under Item 1A of Part I of our Annual Report on Form 10-K, filed with the ~~SEC~~Securities and Exchange Commission on August 2822, ~~2023~~2024.

Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations and assumptions reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We undertake no obligation to publicly update any forward-looking statement after the date of this report, whether as a result of new information, future developments or otherwise, or to conform these statements to actual results or revised expectations, except as may be required by law.

Table of Contents

Part I - FINANCIAL INFORMATION

Item 1. Financial Statements

Paycor HCM, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands, except share amounts)

	March 31,2024		June 30,2023
	September 30,2024		June 30,2024
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	9097,~~098~~618	$	95117,~~233~~958
Accounts receivable, net	43,989		30,820
Accounts receivable, net allowance for credit losses	47,957		48,164
Deferred contract costs	6773,~~156~~128		5470,~~448~~377
Prepaid expenses	1614,~~985~~693		1012,~~448~~749
Other current assets	78,~~772~~673		23,~~581~~458
Current assets before funds held for clients	~~226~~242,~~000~~069		~~193~~252,~~530~~706
Funds held for clients	1967,~~418,233~~189		1,~~049~~109,~~156~~136
Total current assets	1,~~644~~209,~~233~~258		1,~~242~~361,~~686~~842
Property and equipment, net	3534,~~780~~871		3435,~~573~~220
Operating lease right-of-use assets	14,~~968~~021		1614,~~834~~417
Goodwill	766,~~739~~832		~~767~~766,~~738~~653
Intangible assets, net	~~190~~147,~~818~~925		~~260~~171,~~472~~493
Capitalized software, net	6470,~~987~~173		5367,~~983~~376
Long-term deferred contract costs	~~184~~194,~~480~~941		~~162~~189,~~657~~826
Other long-term assets	32,~~344~~853		2,~~232~~566
Total assets	$	2,~~905~~440,~~349~~874	$	2,~~541~~609,~~175~~393
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	20,~~005~~419	$	2827,~~350~~309
Accrued expenses and other current liabilities	2529,~~088~~535		2426,~~119~~450
Accrued payroll and payroll related expenses	3622,~~754~~006		4344,~~858~~923
Deferred revenue	1413,~~017~~124		13,~~083~~600
Current liabilities before client fund obligations	9585,~~864~~084		~~109~~112,~~410~~282
Client fund obligations	1963,~~420,159~~998		1,~~053~~111,~~926~~373
Total current liabilities	1,~~516~~049,~~023~~082		1,~~163~~223,~~336~~655
Deferred income taxes	1311,~~696~~197		1816,~~047~~019
Long-term operating leases	1412,~~009~~653		1613,~~061~~447
Other long-term liabilities	7068,~~251~~309		7069,~~047~~346
Total liabilities	1,~~613~~141,~~979~~241		1,~~267~~322,~~491~~467
Commitments and contingencies (Note 13)
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock $0.001 par value per share, 500,000,000 shares authorized, 178,030,253 shares outstanding at March 31, 2024 and 176,535,236 shares outstanding at June 30, 2023	178		177
Common stock $0.001 par value per share, 500,000,000 shares authorized, 178,821,615 shares outstanding at September 30, 2024 and 178,210,263 shares outstanding at June 30, 2024	179		178
Treasury stock, at cost, 10,620,260 shares at March 31, 2024 and June 30, 2023	(245,074)		(245,074)
Treasury stock, at cost, 10,620,260 shares at September 30, 2024 and June 30, 2024	(245,074)		(245,074)
Preferred stock, $0.001 par value, 50,000,000 shares authorized, — shares outstanding at March 31, 2024 and June 30, 2023	—		—
Preferred stock, $0.001 par value, 50,000,000 shares authorized, — shares outstanding at September 30, 2024 and June 30, 2024	—		—
Additional paid-in capital	2,~~067~~097,~~497~~454		2,~~011~~081,~~194~~668
Accumulated deficit	(~~530~~555,~~147~~721)		(~~489~~548,~~495~~437)
Accumulated other comprehensive loss	(1,084)		(3,118)
Accumulated other comprehensive income (loss)	2,795		(1,409)
Total stockholders' equity	1,~~291~~299,~~370~~633		1,~~273~~286,~~684~~926
Total liabilities and stockholders' equity	$	2,~~905~~440,~~349~~874	$	2,~~541~~609,~~175~~393

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share amounts)

Three Months Ended March 31,

Nine Months Ended March 31,

Three Months Ended September 30,

~~2024~~

~~2023~~

2024

2023

Revenues:

Recurring and other revenue

~~171,973~~

~~150,757~~

~~451~~153,~~913~~999

~~389~~132,~~908~~708

Interest income on funds held for clients

~~15,046~~

~~10,725~~

3813,~~235~~477

2210,~~741~~880

Total revenues

~~187,019~~

~~161,482~~

~~490~~167,~~148~~476

~~412~~143,~~649~~588

Cost of revenues

~~58,736~~

~~49,323~~

~~165~~59,~~239~~217

~~138~~51,~~692~~378

Gross profit

~~128,283~~

~~112,159~~

~~324~~108,~~909~~259

~~273~~92,~~957~~210

Operating expenses:

Sales and marketing

~~55,839~~

~~55,499~~

~~166~~56,~~370~~789

~~155~~52,~~607~~778

General and administrative

~~49,921~~

~~51,033~~

~~154~~48,~~843~~296

~~151~~48,~~405~~749

Research and development

~~15,067~~

~~13,658~~

4517,~~787~~428

3914,~~935~~055

Total operating expenses

~~120,827~~

~~120,190~~

~~367~~122,~~000~~513

~~346~~115,~~947~~582

Income (loss) from operations

7,456

(8,031)

(42,091)

(72,990)

Loss from operations

(14,254)

(23,372)

Other (expense) income:

Interest expense

~~(1,146)~~

~~(1,970)~~

(31,~~543~~138)

(31,~~461~~244)

Other

~~1,133~~

~~2,003~~

~~319~~1,670

~~2,514~~931

Income (loss) before benefit for income taxes

7,443

(7,998)

(45,315)

(73,937)

Loss before benefit for income taxes

(13,722)

(23,685)

Income tax expense (benefit)

1,250

(658)

(4,663)

(10,082)

Income tax benefit

(6,438)

(3,089)

Net income (loss)

6,193

(7,340)

(40,652)

(63,855)

Net loss

(7,284)

(20,596)

Basic and diluted net income (loss) per share

0.03

(0.04)

(0.23)

(0.36)

Basic and diluted net loss per share

(0.04)

(0.12)

Weighted average common shares outstanding:

Basic and diluted

~~177,968,744~~

~~176,306,017~~

~~177~~178,~~494~~729,~~795~~710

~~175~~176,~~879~~953,~~962~~395

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Comprehensive ~~Income (~~Loss)

(in thousands)

	~~Three Months Ended~~		Three Months Ended		~~Nine Months Ended~~
	March 31,				March 31,
			September 30,
	~~2024~~		~~2023~~		2024		2023
Net income (loss)	$	6,193	$	(7,340)	$	(40,652)	$	(63,855)
Net loss					$	(7,284)	$	(20,596)
Other comprehensive (loss) income, net of tax:
Other comprehensive income (loss), net of tax:
Unrealized (loss) gain on foreign currency translation	(154)		21		(139)		(286)
Unrealized gain (loss) on foreign currency translation					110		(168)
Unrealized (loss) gain on available-for-sale securities, net of tax	(926)		641		2,173		175
Unrealized gain (loss) on available-for-sale securities, net of tax					4,094		(174)
Other comprehensive (loss) income, net of tax	(1,080)		662		2,034		(111)
Other comprehensive income (loss), net of tax					4,204		(342)
Comprehensive income (loss)	$	5,113	$	(6,678)	$	(38,618)	$	(63,966)
Comprehensive loss					$	(3,080)	$	(20,938)

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

	Three Months Ended March 31, 2023
	Three Months Ended September 30, 2023
	Preferred Stock			Common Stock					AdditionalPaid-inCapital		AccumulatedDeficit		AccumulatedOtherComprehensiveLoss		TotalStockholders'Equity
	Shares	Amount		Shares	Amount		TreasuryStock
Balance, December 31, 2022	—	$	—	175,856,650	$	176	$	(245,074)	$	1,967,352	$	(451,904)	$	(2,554)	$	1,267,996
Balance, June 30, 2023	—	$	—	176,535,236	$	177	$	(245,074)	$	2,011,194	$	(489,495)	$	(3,118)	$	1,273,684
Net loss	—	—		—	—		—		—		(720,~~340~~596)		—		(720,~~340~~596)
Stock-based compensation expense	—	—		—	—		—		2012,~~384~~915		—		—		2012,~~384~~915
Net settlement for taxes	—	—		—	—		—		(~~423~~418)		—		—		(~~423~~418)
Issuance of common stock under employee stock plans	—	—		~~583~~568,~~772~~781	—		—		34,~~985~~172		—		—		34,~~985~~172
Other comprehensive income	—	—		—	—		—		—		—		662		662
Other comprehensive loss	—	—		—	—		—		—		—		(342)		(342)
Balance, March 31, 2023	—	$	—	176,440,422	$	176	$	(245,074)	$	1,991,298	$	(459,244)	$	(1,892)	$	1,285,264
Balance, September 30, 2023	—	$	—	177,104,017	$	177	$	(245,074)	$	2,027,863	$	(510,091)	$	(3,460)	$	1,269,415

	Three Months Ended March 31, 2024
	Three Months Ended September 30, 2024
	Preferred Stock			Common Stock					AdditionalPaid-inCapital		AccumulatedDeficit		~~AccumulatedOtherComprehensiveLoss~~AccumulatedOtherComprehensive(Loss) Income		TotalStockholders'Equity
	Shares	Amount		Shares	Amount		TreasuryStock
Balance, December 31, 2023	—	$	—	177,634,296	$	178	$	(245,074)	$	2,049,501	$	(536,340)	$	(4)	$	1,268,261
Balance, June 30, 2024	—	$	—	178,210,263	$	178	$	(245,074)	$	2,081,668	$	(548,437)	$	(1,409)	$	1,286,926
Net income	—	—		—	—		—		—		6,193		—		6,193
Net loss	—	—		—	—		—		—		(7,284)		—		(7,284)
Stock-based compensation expense	—	—		—	—		—		1412,~~849~~665		—		—		1412,~~849~~665
Net settlement for taxes	—	—		—	—		—		(~~544~~323)		—		—		(~~544~~323)
Issuance of common stock under employee stock plans	—	—		~~395~~611,~~957~~352	—1		—		3,~~691~~444		—		—		3,~~691~~445
Other comprehensive loss	—	—		—	—		—		—		—		(1,080)		(1,080)
Other comprehensive income	—	—		—	—		—		—		—		4,204		4,204
Balance, March 31, 2024	—	$	—	178,030,253	$	178	$	(245,074)	$	2,067,497	$	(530,147)	$	(1,084)	$	1,291,370
Balance, September 30, 2024	—	$	—	178,821,615	$	179	$	(245,074)	$	2,097,454	$	(555,721)	$	2,795	$	1,299,633

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of ~~Stockholders’~~Cash ~~Equity~~ Flows

(in thousands)

(in thousands, except share amounts)


	Three Months Ended
	September 30,
	2024		2023
Cash flows from operating activities:
Net loss	$	(7,284)	$	(20,596)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,451		1,511
Amortization of intangible assets and software	34,341		34,183
Amortization of deferred contract costs	18,834		14,366
Stock-based compensation expense	12,665		12,915

Deferred tax benefit	(6,795)		(3,098)
Bad debt expense	730		1,291
Loss on sale of investments	83		61

(Gain) loss on foreign currency exchange	(52)		184
Loss (gain) on lease exit	6		(144)
Naming rights accretion expense	1,006		1,030
Change in fair value of deferred consideration	(112)		—


Other	23		23
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(478)		(5,228)
Prepaid expenses and other assets	(6,641)		(6,393)

Accounts payable	(6,848)		(7,877)
Accrued liabilities and other	(21,914)		(21,314)
Deferred revenue	(626)		43

Deferred contract costs	(26,700)		(27,086)
Net cash used in operating activities	(8,311)		(26,129)
Cash flows from investing activities:
Purchases of client funds available-for-sale securities	(83,244)		(22,542)
Proceeds from sale and maturities of client funds available-for-sale securities	78,135		23,652
Purchase of property and equipment	(1,169)		(1,435)

Acquisition of intangible assets	(127)		(12)



Internally developed software costs	(13,441)		(13,254)
Net cash used in investing activities	(19,846)		(13,591)
Cash flows from financing activities:
Net change in cash and cash equivalents held to satisfy client funds obligations	(145,984)		(16,270)



Payment of capital expenditure financing	—		(3,689)





Repayments of debt and finance lease obligations	(297)		(266)




Withholding taxes paid related to net share settlements	(323)		(418)

Proceeds from employee stock purchase plan	3,444		4,172


Net cash used in financing activities	(143,160)		(16,471)
Impact of foreign exchange on cash and cash equivalents	(2)		1
Net change in cash, cash equivalents, restricted cash and short-term investments, and funds held for clients	(171,319)		(56,190)
Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, beginning of period	910,580		879,046
Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, end of period	$	739,261	$	822,856
Supplemental disclosure of non-cash investing, financing and other cash flow information:
Capital expenditures in accounts payable	$	12	$	11

Cash paid for interest	$	—	$	145

Capital lease asset obtained in exchange for capital lease liabilities	$	—	$	3,393
Reconciliation of cash, cash equivalents, restricted cash and short-term investments, and funds held for clients to the Consolidated Balance Sheets
Cash and cash equivalents	$	97,618	$	54,277

Funds held for clients	641,643		768,579
Total cash, cash equivalents, restricted cash and short-term investments, and funds held for clients	$	739,261	$	822,856

	Nine Months Ended March 31, 2023
	Preferred Stock			Common Stock					AdditionalPaid-inCapital		AccumulatedDeficit		AccumulatedOtherComprehensive Income		TotalStockholders'Equity
	Shares	Amount		Shares	Amount		TreasuryStock
Balance, June 30, 2022	—	$	—	174,909,539	$	175	$	(245,074)	$	1,926,800	$	(395,389)	$	(1,781)	$	1,284,731
Net loss	—	—		—	—		—		—		(63,855)		—		(63,855)
Stock-based compensation expense	—	—		—	—		—		58,019		—		—		58,019
Net settlement for taxes	—	—		—	—		—		(2,150)		—		—		(2,150)
Issuance of common stock under employee stock plans	—	—		1,530,883	1		—		8,629		—		—		8,630
Other comprehensive loss	—	—		—	—		—		—		—		(111)		(111)
Balance, March 31, 2023	—	$	—	176,440,422	$	176	$	(245,074)	$	1,991,298	$	(459,244)	$	(1,892)	$	1,285,264

	Nine Months Ended March 31, 2024
	Preferred Stock				Common Stock						AdditionalPaid-inCapital		AccumulatedDeficit		AccumulatedOtherComprehensiveLoss		TotalStockholders'Equity
	Shares		Amount		Shares		Amount		TreasuryStock
Balance, June 30, 2023	—		—		176,535,236		$	177	$	(245,074)	$	2,011,194	$	(489,495)	$	(3,118)	$	1,273,684
Net loss	—		—		—		—		—		—		(40,652)		—		(40,652)
Stock-based compensation expense	—		—		—		—		—		50,813		—		—		50,813
Net settlement for taxes	—		—		—		—		—		(2,373)		—		—		(2,373)
Issuance of common stock under employee stock plans	—		—		1,495,017		1		—		7,863		—		—		7,864
Other comprehensive income	—		—		—		—		—		—		—		2,034		2,034
Balance, March 31, 2024	$	—	$	—	$	178,030,253	$	178	$	(245,074)	$	2,067,497	$	(530,147)	$	(1,084)	$	1,291,370

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

	Nine Months Ended
	March 31,
	2024		2023
Cash flows from operating activities:
Net loss	$	(40,652)	$	(63,855)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	4,464		3,571
Amortization of intangible assets and software	101,872		92,727
Amortization of deferred contract costs	46,524		33,246
Stock-based compensation expense	50,813		58,019
Deferred tax benefit	(4,670)		(10,287)
Bad debt expense	4,937		3,233
Loss on sale of investments	280		232
Loss on foreign currency exchange	186		381
(Gain) loss on lease exit	(24)		950
Naming rights accretion expense	3,066		3,198
Change in fair value of contingent consideration	2,816		—
Other	66		(930)
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(18,124)		(12,063)
Prepaid expenses and other assets	(9,567)		(6,510)
Accounts payable	(8,478)		6,229
Accrued liabilities and other	(13,944)		(19,602)
Deferred revenue	1,190		1,119
Deferred contract costs	(81,055)		(73,273)
Net cash provided by operating activities	39,700		16,385
Cash flows from investing activities:
Purchases of client funds available-for-sale securities	(226,919)		(365,196)
Proceeds from sale and maturities of client funds available-for-sale securities	178,134		259,097
Purchase of property and equipment	(2,451)		(3,285)
Acquisition of intangible assets	(4,954)		(18,842)
Acquisition of businesses, net of cash acquired	82		(18,793)
Internally developed software costs	(38,268)		(30,600)
Net cash used in investing activities	(94,376)		(177,619)
Cash flows from financing activities:
Net change in cash and cash equivalents held to satisfy client funds obligations	364,028		(453,685)
Payment of capital expenditure financing	(3,689)		—
Repayments of debt and finance lease obligations	(809)		(211)
Withholding taxes paid related to net share settlements	(2,373)		(2,150)
Proceeds from exercise of stock options	—		345
Proceeds from employee stock purchase plan	7,864		8,285
Net cash provided by (used in) financing activities	365,021		(447,416)
Impact of foreign exchange on cash and cash equivalents	(3)		(15)
Net change in cash, cash equivalents, restricted cash and short-term investments, and funds held for clients	310,342		(608,665)
Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, beginning of period	879,046		1,682,923
Cash, cash equivalents, restricted cash and short-term investments, and funds held for clients, end of period	$	1,189,388	$	1,074,258
Supplemental disclosure of non-cash investing, financing and other cash flow information:
Capital expenditures in accounts payable	$	20	$	2
Cash paid for interest	$	145	$	—
Right-of-use assets obtained in exchange for operating lease liabilities	$	—	$	6,257
Capital lease asset obtained in exchange for capital lease liabilities	$	3,393	$	—
Reconciliation of cash, cash equivalents, restricted cash and short-term investments, and funds held for clients to the Consolidated Balance Sheets
Cash and cash equivalents	$	90,098	$	82,858
Funds held for clients	1,099,290		991,400
Total cash, cash equivalents, restricted cash and short-term investments, and funds held for clients	$	1,189,388	$	1,074,258

The accompanying Notes to the Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

Paycor HCM, Inc. and Subsidiaries

Notes to the Unaudited Condensed Consolidated Financial Statements

(all amounts in thousands, except share and per share data)

1. ORGANIZATION AND DESCRIPTION OF BUSINESS:

Paycor HCM, Inc. (“Paycor HCM” or “the Company”) is a leading provider of human capital management (“HCM”) software located primarily in the United States (“U.S.”). Paycor’s solutions target ~~small and medium~~mid-~~sized~~market businesses with tens to thousands of employees. Solutions provided include payroll, human resources (“HR”) services, talent acquisition, talent management, workforce management, benefits administration, reporting and analytics, and other payroll-related services. Services are generally provided in a Software-as-a-Service (“SaaS”) delivery model utilizing a cloud-based platform.

Paycor HCM is a holding company with no material operating assets or operations that was formed on August 24, 2018 to effect the acquisition of Paycor, Inc. and its subsidiaries (“Paycor”) by certain investment funds ~~(the “Apax Funds”)~~ advised by Apax Partners LLP, a leading global private equity advisory firm ~~(“Apax Partners”)~~. On September 7, 2018, Paycor HCM, through its subsidiary companies, entered into the Agreement and Plan of Merger to acquire Paycor (the “Apax Acquisition”). The Apax Acquisition closed on November 2, 2018. As a result of the Apax Acquisition, Paycor became an indirect controlled subsidiary of Paycor HCM.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Basis of presentation and consolidation

The accompanying interim unaudited condensed consolidated financial statements of the Company were prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim reporting. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended June 30, ~~2023~~2024 in the Company’s Annual Report on Form 10-K filed with the ~~Securities~~SEC ~~and Exchange Commission~~ on August 2822, ~~2023~~2024. The unaudited condensed consolidated financial statements for interim periods do not include all disclosures required by U.S. GAAP for annual financial statements and are not necessarily indicative of results for any future interim periods and the full fiscal year ending June 30, ~~2024~~2025. Adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of the unaudited condensed consolidated financial position, results of operations and cash flows at the dates and for the periods presented have been included. All intercompany transactions and balances have been eliminated in consolidation.

Recently issued accounting standards

In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU 2023-09 requires entities to further enhance their income tax disclosures, primarily through the standardization and disaggregation of information within an entity’s effective tax rate reconciliation categories and income taxes paid by jurisdiction. The guidance will be effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The guidance is required to be applied on a prospective basis with the option to apply the guidance retrospectively. The Company is currently evaluating whether it will adopt the guidance prospectively or retroactively and the impact the guidance will have on its financial statement disclosures.

Use of estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the evaluation of potential impairment of goodwill and intangible assets and the valuation of stock-based compensation.

The Company’s results of operations and financial condition can also be affected by economic, political, legislative, regulatory and legal actions, including but not limited to health epidemics and pandemics and their resulting economic impact. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, and government fiscal policies can have a significant effect on the Company’s results of operations and financial condition. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.

~~Accounts receivable, net~~ 10

Accounts receivable, ~~balances are shown on the unaudited condensed consolidated balance sheets~~ net of ~~the~~ allowance for ~~doubtful accounts of $11,880 and $7,032 as of March 31, 2024 and June 30, 2023, respectively. The allowance for doubtful accounts considers factors such as historical experience,~~ credit quality, age of the accounts receivable balance and current and forecasted economic conditions that may affect a client’s ability to pay. The Company performs ongoing credit evaluations and generally requires no collateral from clients. Management reviews individual accounts as they become past due to determine collectability. The allowance for doubtful accounts is adjusted periodically based on management’s consideration of past due accounts. Individual accounts are charged against the allowance when all reasonable collection efforts have been exhausted. losses

11Accounts receivable balances are shown on the unaudited condensed consolidated balance sheets net of the allowance for credit losses of $6,797 and $6,358 as of September 30, 2024 and June 30, 2024, respectively. The allowance for credit losses considers factors such as historical experience, credit quality, age of the accounts receivable balance and current and forecasted economic conditions that may affect a client’s ability to pay. The Company performs ongoing credit evaluations and generally requires no collateral from clients. Management reviews individual accounts as they become past due to determine collectability. The allowance for credit losses is adjusted periodically based on management’s consideration of past due accounts as well as current and forecasted economic conditions. Individual accounts are charged against the allowance when all reasonable collection efforts have been exhausted.

Sales and marketing

Sales and marketing expenses consist of costs associated with the Company’s direct sales and marketing staff, including employee-related costs, marketing, advertising and promotion expenses, and other related costs. Advertising and promotion costs are expensed as incurred. Advertising and promotion ~~expenses~~expense totaled approximately $8,~~459~~480 and $87,~~014~~831 for the three months ended ~~March~~September 3130, 2024 and 2023, respectively. ~~Advertising and promotion expenses totaled approximately $24,730 and $21,415 for the nine months ended March 31, 2024 and 2023, respectively.~~

Stock-based compensation

The Company recognizes all employee and director stock-based compensation as a cost in the unaudited condensed consolidated financial statements. Equity-classified awards are measured at the grant date fair value of the award and expense is recognized, net of actual forfeitures, on a straight-line basis over the requisite service period for the award.

The Company establishes the grant date fair value of restricted stock units (“RSUs”) based on the fair value of the Company's underlying common stock. The Company estimates the grant date fair value of stock options, including common stock purchased as a part of the Company's Employee Stock Purchase Plan (“ESPP”), using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of the Company's award on the grant date, including the expected term of the award, the expected volatility of the Company's stock calculated based on a period of time generally commensurate with the expected term of the award, the expected risk-free rate of return, and expected dividend yields of the Company's stock. The Company recognized stock-based compensation expense for the three months ended ~~March~~September 3130, 2024 and 2023 of $1412,~~849~~665 and $2012,~~384~~915, respectively. ~~The Company recognized stock-based compensation expense for the nine months ended March 31, 2024 and 2023 of $50,813 and $58,019, respectively.~~

3. REVENUE:

The following table disaggregates revenue from contracts by recurring fees and implementation services and other, which the Company believes depicts the nature, amount and timing of its revenue:

Three Months Ended March 31,

Nine Months Ended March 31,

Three Months Ended September 30,

~~2024~~

~~2023~~

2024

2023

Recurring fees

~~168,105~~

~~147,491~~

~~440~~149,~~616~~555

~~380~~129,~~426~~181

Implementation services and other

~~3,868~~

~~3,266~~

114,~~297~~444

93,~~482~~527

Recurring and other revenue

~~171,973~~

~~150,757~~

~~451~~153,~~913~~999

~~389~~132,~~908~~708

Deferred revenue

The Company recognizes deferred revenue for nonrefundable upfront fees as well as for subscription services related to certain ancillary products invoiced prior to the satisfaction of the performance obligation.

The nonrefundable upfront fees related to implementation services are typically included on the client’s first invoice. Implementation fees are deferred and recognized as revenue over an estimated 24-month period to which the material right exists, which is the period the client is expected to benefit from not having to pay an additional nonrefundable implementation fee upon renewal of the service.

1211

The following table summarizes the changes in deferred revenue related to the nonrefundable upfront fees and recurring subscription services:

	Three Months Ended March 31,				Nine Months Ended March 31,
			Three Months Ended September 30,
	~~2024~~		~~2023~~		2024		2023
Balance, beginning of period	$	~~18,952~~	$	~~17,037~~	$	1819,~~697~~318	$	1718,~~046~~697
Deferred revenue acquired	—		7		—		300
Deferral of revenue					4,164		4,888
Deferral of revenue	6,391		6,279		16,444		16,186
Revenue recognized					(4,789)		(4,844)
Revenue recognized	(5,458)		(4,949)		(15,252)		(15,052)
Impact of foreign exchange					8		(29)
Impact of foreign exchange	(23)		(4)		(27)		(110)
Balance, end of period					$	18,701	$	18,712
Balance, end of period	$	19,862	$	18,370	$	19,862	$	18,370

Deferred revenue is recorded within deferred revenue and other long-term liabilities on the unaudited condensed consolidated balance sheets. The Company will recognize deferred revenue of $410,~~192~~684 in fiscal year ~~2024~~2025, $117,~~822~~102 in fiscal year ~~2025~~2026, and $~~3,848~~915 in fiscal year ~~2026~~2027.

Deferred contract costs

The following table presents the deferred contract costs balance and related amortization expense for these deferred contract costs.


	As of and for the Three Months Ended September 30, 2024
	Beginning Balance		Capitalization of Costs		Amortization		Ending Balance
Costs to obtain a contract	$	108,583	$	11,052	$	(8,019)	$	111,616
Costs to fulfill a contract	151,620		15,648		(10,815)		156,453
Total	$	260,203	$	26,700	$	(18,834)	$	268,069

As of and for the Three Months Ended March 31, 2024

As of and for the Three Months Ended September 30, 2023

Beginning Balance

Capitalization of Costs

Amortization

Ending Balance

Costs to obtain a contract

~~101~~93,~~235~~317

10,~~880~~653

(76,~~111~~221)

~~105~~97,~~004~~749

Costs to fulfill a contract

~~139~~123,~~898~~788

16,~~271~~433

(98,~~537~~145)

~~146~~132,~~632~~076

Total

~~241~~217,~~133~~105

27,~~151~~086

(1614,~~648~~366)

~~251~~229,~~636~~825

	As of and for the Three Months Ended March 31, 2023
	Beginning Balance		Capitalization of Costs		Amortization		Ending Balance
Costs to obtain a contract	$	82,423	$	10,559	$	(5,316)	$	87,666
Costs to fulfill a contract	107,482		15,189		(6,836)		115,835
Total	$	189,905	$	25,748	$	(12,152)	$	203,501

The Company capitalizes costs associated with obtaining and fulfilling revenue contracts. Deferred contract costs are recorded within deferred contract costs and long-term deferred contract costs on the unaudited condensed consolidated balance sheets and amortized over the expected period of benefit of six years, which the Company has determined to be the estimated average client life. Amortization of costs to fulfill a contract and costs to obtain a contract are recorded in cost of revenues and sales and marketing expenses in the unaudited condensed consolidated statements of operations, respectively. The Company regularly reviews its deferred contract costs for impairment and did not recognize any such impairment loss during any period presented in this report.

	As of and for the Nine Months Ended March 31, 2024
	Beginning Balance		Capitalization of Costs		Amortization		Ending Balance
Costs to obtain a contract	$	93,317	$	31,685	$	(19,998)	$	105,004
Costs to fulfill a contract	123,788		49,370		(26,526)		146,632
Total	$	217,105	$	81,055	$	(46,524)	$	251,636

4. FUNDS HELD FOR CLIENTS:

	As of and for the Nine Months Ended March 31, 2023
	Beginning Balance		Capitalization of Costs		Amortization		Ending Balance
Costs to obtain a contract	$	72,342	$	29,949	$	(14,625)	$	87,666
Costs to fulfill a contract	91,132		43,324		(18,621)		115,835
Total	$	163,474	$	73,273	$	(33,246)	$	203,501

Deferred contract costs are recorded within deferred contract costs and long-term deferred contract costs on the unaudited condensed consolidated balance sheets. Amortization of costs to fulfill a contract and costs to obtain a contract are recorded in

cost of revenues and sales and marketing expenses in the unaudited condensed consolidated statements of operations, respectively. The Company regularly reviews its deferred costs for impairment and did not recognize an impairment loss during any period presented.

4. BUSINESS COMBINATION AND ASSET ACQUISITION:

Acquisition of Verb, Inc.

On May 2, 2023, the Company acquired 100% of the equity interests of Verb, Inc., a modern behavioral science-based microlearning solution to develop frontline leaders and their teams (the “Verb Acquisition”), for an initial cash purchase price of $6,000, plus up to a maximum of $2,000 in additional cash payments based on the achievement of an established earnout. The acquisition was funded with cash on hand.

The acquisition was accounted for as a business combination. The preliminary purchase price was allocated to the assets acquired and liabilities assumed based on the estimated fair value of the total consideration transferred at the date of acquisition. The excess of the purchase price over the fair value of the net assets acquired was allocated to goodwill, none of which is deductible for tax purposes. Goodwill consists primarily of the synergistic benefits and growth opportunities. The factors contributing to the recognition of goodwill were based on strategic benefits that are expected to be realized from the Verb Acquisition. The benefits include acquiring a software technology tailored to small and medium-sized businesses that can be integrated into the current suite of the Company’s products. The preliminary purchase price for the Verb Acquisition was allocated to individual assets acquired and liabilities assumed as follows:

	May 2, 2023
Fair value of total consideration	$	5,677
Cash acquired	(295)
Net purchase price	$	5,382
Assets acquired:
Accounts receivable	$	144
Other current assets	119
Property and equipment	22
Technology intangible assets	2,680
Other non-current assets	586
Total identifiable assets acquired	3,551
Liabilities assumed:
Accounts payable	(49)
Accrued expenses	(96)
Deferred revenue	(749)
Total identifiable liabilities assumed	(894)
Goodwill	2,725
Fair value of total consideration transferred	$	5,382

The technology intangible assets acquired have a weighted average useful life of 3 years.

The fair value of the contingent consideration was measured at the acquisition date based on management’s estimate of future payments and recorded as a liability within other long-term liabilities on the unaudited condensed consolidated balance sheets.

Acquisition of Talenya Ltd.

On October 27, 2022, the Company acquired 100% of the equity interests of Talenya Ltd., an Israeli-based provider of an artificial intelligence-driven solution for talent sourcing and recruiting employees (the “Talenya Acquisition”), for an initial

cash purchase price of $20,000, plus up to a maximum of $10,000 in additional cash payments based on the achievement of established earnouts over a two-year period. The acquisition was funded with cash on hand.

The acquisition was accounted for as a business combination. The preliminary purchase price was allocated to the assets acquired and liabilities assumed based on the estimated fair value of the total consideration transferred at the date of acquisition. The excess of the purchase price over the fair value of the net assets acquired was allocated to goodwill, none of which is deductible for tax purposes. Goodwill consists primarily of the synergistic benefits and growth opportunities. The factors contributing to the recognition of goodwill were based on strategic benefits that are expected to be realized from the Talenya Acquisition. The benefits include acquiring a software technology tailored to small and medium-sized businesses that can be integrated into the current suite of the Company’s products. The final purchase price for the Talenya Acquisition was allocated to individual assets acquired and liabilities assumed as follows:

	October 27, 2022
Fair value of total consideration	$	23,240
Cash acquired	(172)
Net purchase price	$	23,068
Assets acquired:
Accounts receivable	$	217
Other current assets	34
Property and equipment	13
Technology intangible assets	6,760
Other non-current assets	2,222
Total identifiable assets acquired	9,246
Liabilities assumed:
Accounts payable	(211)
Accrued expenses	(294)
Deferred revenue	(300)
Total identifiable liabilities assumed	(805)
Goodwill	14,627
Fair value of total consideration transferred	$	23,068

The technology intangible assets acquired have a weighted average useful life of 7 years.

The fair value of the contingent consideration was measured at the acquisition date based on management’s estimate of future payments and recorded as a liability within accrued expenses and other current liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets.

The Company incurred transaction costs of $— related to the Talenya Acquisition for both the three months ended March 31, 2024 and 2023 and $— and $1,174 related to the Talenya Acquisition for the nine months ended March 31, 2024 and 2023, respectively. These costs were expensed as incurred in general and administrative expenses within the accompanying unaudited condensed consolidated statements of operations.

Asset Acquisitions

The Company periodically acquires customer relationships from other HCM providers. The asset purchase agreements usually provide for an initial payment as well as contingent payments to the seller based on revenue generated by the acquired clients over a defined timeframe. Contingent payments made under such agreements for both the three months ended March 31, 2024 and 2023 were $—. Contingent payments made under such agreements for the nine months ended March 31, 2024 and 2023 were $3,596 and $4,259, respectively.

The acquired customer relationships are recorded within intangible assets on the unaudited condensed consolidated balance sheets and are being amortized on a straight-line basis over three years. As of March 31, 2024, the weighted average remaining amortization period for these intangible assets was approximately 1.9 years. The contingent payments were recognized when

each contingency was resolved and the consideration was paid or became payable as an increase to the acquired intangible asset, amortized on a straight-line basis over the remaining period of the initial acquired intangible asset.

5. FUNDS HELD FOR CLIENTS:

Funds held for clients are as follows:

	March 31, 2024
	September 30, 2024
	AmortizedCost		GrossUnrealizedGains		GrossUnrealizedLosses		FairValue
Demand deposit accounts and other cash equivalents	$	1641,~~099,290~~643	$	—	$	—	$	1641,~~099,290~~643
U.S. Treasury and direct obligations of U.S. government agencies	8670,~~707~~221		331,221		(~~315~~20)		8671,~~425~~422
Corporate bonds	~~212~~230,~~839~~102		~~214~~2,940		(~~1,048~~500)		~~212~~232,~~005~~542
Commercial paper	618		—		—		618
Other securities	21,424		244		(86)		21,582
Other securities	20,042		17		(164)		19,895
	$	963,390	$	4,405	$	(606)	$	967,189
	$	1,419,496	$	264	$	(1,527)	$	1,418,233

	June 30, 2023
	AmortizedCost		GrossUnrealizedGains		GrossUnrealizedLosses		FairValue
Demand deposit accounts and other cash equivalents	$	783,813	$	—	$	—	$	783,813
U.S. Treasury and direct obligations of U.S. government agencies	72,173		—		(776)		71,397
Corporate bonds	172,570		91		(3,049)		169,612
Commercial paper	2,977		—		(3)		2,974
Other securities	21,776		2		(418)		21,360
	$	1,053,309	$	93	$	(4,246)	$	1,049,156

Other securities are primarily comprised of municipal obligations and certificates of deposit.


	June 30, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Demand deposit accounts and other cash equivalents	$	792,622	$	—	$	—	$	792,622
U.S. Treasury and direct obligations of U.S. government agencies	91,378		18		(413)		90,983
Corporate bonds	206,981		123		(1,178)		205,926

Other securities	19,783		9		(187)		19,605
	$	1,110,764	$	150	$	(1,778)	$	1,109,136

~~Proceeds~~Other ~~from sales and maturities of investment~~ securities ~~for~~are ~~the~~primarily ~~three~~comprised ~~months ended March 31, 2024 and 2023 were approximately $74,680 and $45,080, respectively. Proceeds from sales and maturities~~ of ~~investment~~municipal ~~securities for the nine months ended March 31, 2024 and 2023 were approximately $178,134 and $259,097, respectively~~obligations.

Proceeds from sales and maturities of investment securities for the three months ended September 30, 2024 and 2023, were approximately $78,135 and $23,652, respectively.

The Company is exposed to interest rate risk as rate volatility will cause fluctuations in the earnings potential of future investments. The Company does not utilize derivative financial instruments to manage interest rate risk.

The Company reviews its investments on an ongoing basis to determine if any allowance for credit loss is warranted due to changes in credit risk or other potential valuation concerns. The Company has no material individual securities that have been in a continuous unrealized loss position greater than twelve months. The Company believes unrealized losses, to the extent they exist, generally result from changes in interest rates rather than credit risk, and therefore does not believe the related investments need to be assessed to determine whether an allowance for the credit loss is warranted. Additionally, the Company believes it will recover its cost basis in the securities with unrealized losses and has the ability to hold the securities until they recover in value and had no intent to sell them at ~~March~~September 3130, 2024.

16Expected maturities as of September 30, 2024 for client fund assets are as follows:

Expected maturities as of March 31, 2024 for client fund assets are as follows:


Due within fiscal year 2025	$	686,358
Due within fiscal year 2026	89,683
Due within fiscal year 2027	112,231
Due within fiscal year 2028	48,595
Due within fiscal year 2029	16,374
Thereafter	13,948
Total	$	967,189

Due within fiscal year 2024	$	1,110,120
Due within fiscal year 2025	68,232
Due within fiscal year 2026	127,759
Due within fiscal year 2027	80,870
Due within fiscal year 2028	23,368
Thereafter	7,884
Total	$	1,418,233

65. PROPERTY AND EQUIPMENT, NET:

A summary of the Company’s property and equipment, net is as follows:

	March 31,2024		June 30,2023
	September 30,2024		June 30,2024
Land	$	3,680	$	3,680
Land improvements	910		910
Building and improvements	22,845		22,845
Computer, equipment and software	2324,~~135~~700		1823,~~702~~824
Furniture and fixtures	2,~~248~~253		2,~~250~~249
Office equipment	2,~~903~~913		2,~~880~~902
Leasehold improvements	5,~~207~~261		45,~~114~~205
	60,928		55,381
Construction in progress	329		174
Accumulated depreciation and amortization	(25,148)		(20,808)
	62,891		61,789
Property and equipment, net	$	35,780	$	34,573
Accumulated depreciation and amortization	(28,020)		(26,569)
Property and equipment, net	$	34,871	$	35,220

Depreciation and amortization of property and equipment was approximately $1,~~467~~451 and $1,~~175~~511 for the three months ended ~~March~~September 3130, 2024 and 2023, respectively. ~~Depreciation and amortization of property and equipment was approximately $4,464 and $3,571 for the nine months ended March 31, 2024 and 2023, respectively.~~

76. CAPITALIZED SOFTWARE, NET:

A summary of the Company’s capitalized software, net is as follows:

	March 31,2024		June 30,2023
	September 30,2024		June 30,2024
Capitalized software	$	~~163~~189,~~976~~961	$	~~125~~176,~~707~~519
Accumulated amortization	(98119,~~989~~788)		(71109,~~724~~143)
Capitalized software, net	$	6470,~~987~~173	$	5367,~~983~~376

Amortization expense for capitalized software was approximately $910,~~625~~645 and $78,~~166~~473 for the three months ended ~~March~~September 3130, 2024 and 2023, respectively. ~~Amortization expense for capitalized software was approximately $27,264 and $20,317 for the nine months ended March 31, 2024 and 2023, respectively.~~

17The following is a schedule of future amortization expense as of September 30, 2024:

The following is a schedule of future amortization expense as of March 31, 2024:


2025 (remaining nine months)	$	29,350
2026	28,326
2027	12,127
2028	370

	$	70,173

2024 (remaining three months)	$	9,448
2025	31,651
2026	19,695
2027	4,193
	$	64,987

7. GOODWILL AND INTANGIBLE ASSETS:

8. GOODWILL AND INTANGIBLE ASSETS:

Changes in the carrying amount of goodwill are presented below:

Balance at June 30, 2023	$	767,738
Balance at June 30, 2024	$	766,653
Verb Acquisition	(661)
Foreign currency translation	179
Foreign currency translation	(338)
Balance at September 30, 2024	$	766,832
Balance at March 31, 2024	$	766,739

On August 7, 2022, the Company entered into a 16-year partnership with the Cincinnati Bengals of the National Football League that grants the Company exclusive naming rights to Paycor Stadium (the “Naming Rights”), home to the Cincinnati Bengals since 2000. Contractual payments under the naming rights agreement (the “Naming Rights Agreement”) began in August 2022 and end in 2038.

The Naming Rights have been recorded within intangible assets on the unaudited condensed consolidated balance sheet in an amount equal to the present value of the future contractual cash flows with an offsetting liability for payments to be made in the future. The intangible asset reflects the Naming Rights to the Bengals stadium including co-branding and shared promotion, along with the right for the Company to place its logo on and around the stadium.

The discount between the offsetting liability and overall payment obligation is amortized to interest expense over the term of the Naming Rights Agreement using the effective interest method. The intangible asset is being amortized over the life of the Naming Rights Agreement on a straight-line basis through sales and marketing expenses. The liability is included within accrued expenses and other current liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets.

Components of intangible assets were as follows:

	March 31,2024		June 30,2023
	September 30,2024		June 30,2024
Cost:
Technology	$	153,~~011~~690	$	~~151~~153,~~855~~562
Customer relationships	~~466~~469,~~248~~583		~~462~~469,~~452~~583
Trade name	105,670		105,670
Naming rights	66,698		66,698
Total cost	$	~~791~~795,~~627~~641	$	~~786~~795,~~675~~513
Accumulated amortization:
Technology	$	(~~144~~145,~~057~~745)	$	(~~141~~144,~~309~~870)
Customer relationships	(~~411~~451,~~523~~103)		(~~348~~431,~~123~~101)
Trade name	(3841,~~171~~693)		(3239,~~889~~932)
Naming rights	(79,~~058~~175)		(38,~~882~~117)
Total accumulated amortization	$	(~~600~~647,~~809~~716)	$	(~~526~~624,~~203~~020)
Intangible assets, net	$	~~190~~147,~~818~~925	$	~~260~~171,~~472~~493

18Amortization expense for intangible assets was approximately $23,696 and $25,710 for the three months ended September 30, 2024 and 2023, respectively.

~~Amortization~~The ~~expense~~following ~~for~~is ~~intangible~~a ~~assets~~schedule ~~was~~of ~~approximately~~future ~~$23,935~~amortization ~~and $24,467 for the three months ended March 31, 2024 and 2023, respectively. Amortization~~ expense ~~for~~as ~~intangible~~of ~~assets was approximately $74,608 and $72,410 for the nine months ended March~~September 3130, 2024: ~~and 2023, respectively.~~

The following is a schedule of future amortization expense as of March 31, 2024:


2025 (remaining nine months)	$	23,550
2026	19,187
2027	12,456
2028	12,244
2029	12,244
Thereafter	68,244
	$	147,925

2024 (remaining three months)	$	23,028
2025	44,853
2026	17,779
2027	12,420
2028	12,244
Thereafter	80,494
	$	190,818

98. DEBT AGREEMENTS AND LETTERS OF CREDIT:

Credit Agreement

Paycor, Inc. is party to a credit agreement (as amended, the “Credit Agreement”) with PNC Bank, National Association (“PNC”), Fifth Third, National Association, and other lenders, providing a $200,000 senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility includes an “accordion feature” that allows the Company, under certain circumstances, to increase the size of the Revolving Credit Facility by an additional principal amount of up to $200,000, with a resulting maximum principal amount of $400,000, subject to the participating lenders electing to increase their commitments or new lenders being added to the Credit Agreement. The Revolving Credit Facility will mature on June 11, 2026.

The Company had no outstanding borrowings under the Revolving Credit Facility as of ~~March~~September 3130, 2024 and June 30, ~~2023~~2024. Additionally, the Company had no outstanding letters of credit as of ~~March~~September 3130, 2024 and June 30, ~~2023~~2024.

109. FAIR VALUE MEASUREMENTS:

U.S. GAAP defines fair value, establishes a framework for measuring fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels:

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities the Company can access.

Level 2 inputs are inputs (other than quoted prices included within Level 1) that are observable for the asset or liability, either directly or indirectly.

Level 3 inputs are unobservable inputs for the asset or liability and rely on management’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.

The fair value of certain assets, such as nonfinancial assets, primarily long-lived assets, goodwill, intangible assets and certain other assets, are recognized or disclosed in connection with impairment evaluations. All non-recurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy.

The carrying amounts of financial instruments including cash and cash equivalents, accounts receivable, and accounts payable approximated fair value as of ~~March~~September 3130, 2024 and June 30, ~~2023~~2024, because of the relatively short maturity of these instruments.

The following table presents information on the Company’s financial assets and liabilities measured at fair value on a recurring basis as of ~~March~~September 3130, 2024 and June 30, ~~2023~~2024:


	September 30, 2024
	Level 1		Level 2		Level 3		Total
Funds held for clients—cash and cash equivalents:
Demand deposit accounts and other cash equivalents	$	641,643	$	—	$	—	$	641,643
Funds held for clients—available-for-sale:
U.S. Treasury and direct obligations of U.S. government agencies	—		71,422		—		71,422
Corporate bonds	—		232,542		—		232,542

Other securities	—		21,582		—		21,582
	$	641,643	$	325,546	$	—	$	967,189

	March 31, 2024
	Level 1		Level 2		Level 3		Total
Funds held for clients—cash and cash equivalents:
Demand deposit accounts and other cash equivalents	$	1,099,290	$	—	$	—	$	1,099,290
Funds held for clients—available-for-sale:
U.S. Treasury and direct obligations of U.S. government agencies	—		86,425		—		86,425
Corporate bonds	—		212,005		—		212,005
Commercial paper	—		618		—		618
Other securities	—		19,895		—		19,895
	$	1,099,290	$	318,943	$	—	$	1,418,233

	June 30, 2023
	June 30, 2024
	Level 1		Level 2		Level 3		Total
Funds held for clients—cash and cash equivalents:
Demand deposit accounts and other cash equivalents	$	~~783~~792,~~813~~622	$	—	$	—	$	~~783~~792,~~813~~622
Funds held for clients—available-for-sale:
U.S. Treasury and direct obligations of U.S. government agencies	—		7190,~~397~~983		—		7190,~~397~~983
Corporate bonds	—		~~169~~205,~~612~~926		—		~~169~~205,~~612~~926
Commercial paper	—		2,974		—		2,974
Other securities	—		19,605		—		19,605
Other securities	—		21,360		—		21,360
	$	792,622	$	316,514	$	—	$	1,109,136
	$	783,813	$	265,343	$	—	$	1,049,156

~~Available-for-sale~~Cash ~~securities~~and cash equivalents included in Level 1 are valued using closing prices for identical instruments that are traded on active exchanges. Available-for-sale securities included in Level 2 are valued by reference to quoted prices of similar assets ~~or liabilities~~ in active markets, adjusted for any terms specific to that asset ~~or liability~~.

1110. CAPITAL STOCK:

The Company’s Second Amended and Restated Certificate of Incorporation ~~authorized~~authorizes the issuance of up to 500,000,000 shares of common stock with a par value of $0.001 per share and 50,000,000 shares of preferred stock with a par value of $0.001 per share. As of ~~March~~September 3130, 2024 and June 30, ~~2023~~2024, there were 178,~~030~~821,~~253~~615 and ~~176~~178,~~535~~210,~~236~~263 shares of common stock outstanding, respectively, and no shares of preferred stock outstanding.

On March 6, 2024, our principal stockholder, Pride Aggregator, LP (“Pride Aggregator”), which is the investment vehicle controlled by certain funds advised by Apax Partners LLP, completed a secondary underwritten public offering of 8,000,000 shares of the Company’s common stock11. ~~The~~NET ~~Company~~LOSS ~~did~~PER ~~not receive any proceeds from this sale.~~SHARE:

~~12.~~Basic ~~NET~~net ~~INCOME~~loss ~~(LOSS)~~per ~~PER~~share ~~SHARE:~~is calculated by dividing net loss by the weighted average shares of common stock outstanding during the period.

~~Basic~~Diluted net income (loss) per share is ~~calculated~~computed by dividing net income (loss) adjusted as necessary for the impact of potentially dilutive securities, by the weighted average shares outstanding during the period and the impact of ~~common~~securities ~~stock~~that ~~outstanding~~would have a dilutive effect. Potentially dilutive securities during the ~~period~~three months ended September 30, 2024 and 2023 included RSUs, stock options and ESPP purchase rights. Due to the net loss for both the three months ended September 30, 2024 and 2023, any potentially dilutive securities were excluded from the denominator in calculating diluted net loss per share because including them would have had an anti-dilutive effect. Additionally, the Company excluded the impact of stock-based compensation awards held by certain employees consisting of membership interest units in Pride Aggregator for both the three months ended September 30, 2024 and 2023.

~~Diluted~~ Basic ~~net~~and ~~income~~diluted (net loss) per share iswas ~~computed~~the bysame ~~dividing~~for ~~net~~each ~~income~~period ~~(loss)~~presented, ~~adjusted~~ as ~~necessary for~~ the ~~impact~~inclusion of ~~potentially~~all ~~dilutive~~potential ~~securities,~~common ~~by the weighted average~~ shares outstanding ~~during the period and the impact of securities that~~ would have abeen anti-dilutive ~~effect~~. ~~Potentially~~The ~~dilutive~~following ~~securities~~table ~~during~~sets ~~the~~forth ~~three and nine months ended March 31, 2024 and 2023 included RSUs, stock options and ESPP purchase rights. Due to~~ the ~~net~~computation ~~loss~~of ~~for~~basic ~~the nine months ended March 31, 2024~~ and ~~both the three and nine months ended March 31, 2023, any potentially dilutive securities were excluded from the denominator in calculating~~ diluted net loss per share because including them would have had an anti-dilutive effect. Additionally, the Company excluded the impact of stock-based compensation awards held by certain employees consisting of membership interest units in Pride Aggregator for both the three and nine months ended March 31, 2024 and 2023.:


	Three Months Ended September 30,
(in thousands, except per share data)		2024		2023
Net loss		$	(7,284)	$	(20,596)
Weighted average common shares outstanding:
Basic and diluted		178,729,710		176,953,395
Basic and diluted net loss per share		$	(0.04)	$	(0.12)

	Three Months Ended March 31,				Nine Months Ended March 31,
(in thousands, except per share data)	2024		2023		2024		2023
Net income (loss)	$	6,193	$	(7,340)	$	(40,652)	$	(63,855)
Weighted average common shares outstanding:
Basic and diluted	177,968,744		176,306,017		177,494,795		175,879,962
Basic and diluted net income (loss) per share	$	0.03	$	(0.04)	$	(0.23)	$	(0.36)

1312. COMMITMENTS AND CONTINGENCIES:

The Company is subject to various claims, litigation and regulatory compliance matters in the normal course of business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. The resolution of these claims, litigation and regulatory compliance matters, individually or in the aggregate, is not expected to have a material adverse impact on the Company’s unaudited condensed consolidated statements of operations, balance sheets or statements of cash flows. These matters are subject to inherent uncertainties and management’s view of these matters may change in the future.

2113. SUBSEQUENT EVENT:

On October 1, 2024, the Company granted performance-based restricted stock units (“PSUs”) to certain executive officers and other employees. The PSUs are subject to both time-based and performance-based vesting and are eligible to performance-vest based on the achievement of specific revenue and net retention performance goals, each as measured over a one-year performance period commencing on the grant date. One-third of the PSUs that performance-vest at the end of such one-year performance period will be deemed fully vested, subject to continued employment through such date, and the remaining performance-vested PSUs will be subject to continued time-vesting, with such performance-vested PSUs time-vesting quarterly over the two-year period following the performance period, subject to continued employment through each such time-vesting date. The total number of shares underlying the PSUs granted on October 1, 2024 was 806,455, with a target grant date fair value of $11,444 which was based on the Company’s stock price as of September 30, 2024. The Company will recognize compensation expense related to the PSUs granted over the three-year vesting period.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis summarizes the significant factors affecting our unaudited condensed consolidated operating results, financial condition, liquidity, and cash flows as of and for the periods presented below. The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this report as well as management’s discussion and analysis and audited consolidated financial statements included in our most recent Annual Report on Form 10-K. This discussion and analysis reflects our historical results of operations and financial position. The discussion contains forward-looking statements that are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those discussed in or implied by forward-looking statements because of various factors, including those discussed elsewhere in this report, particularly under the caption entitled “Note Regarding Forward-Looking Statements” in this report, and Item 1A. “Risk Factors” in ~~our~~Part ~~most~~I ~~recent~~of our Annual Report on Form 10-K ~~and in our other filings with the Securities and Exchange Commission (“SEC”).~~

filed with the Securities and Exchange Commission (“SEC”) on August 22, 2024 (“2024 Form 10-K”) and in our other reports filed from time to time with the SEC.

Unless we state otherwise or the context otherwise requires, the terms “we,” “us,” and “our” and similar references refer to the Company and its consolidated subsidiaries.

Overview

We are a leading provider of human capital management (“HCM”) software. Our solutions target ~~small and medium~~mid-~~sized~~market businesses with tens to thousands of employees. Our unified, cloud-based platform is designed to empower leaders to ~~build~~drive ~~winning~~business ~~teams~~results by ~~modernizing~~connecting them to people, ~~management~~data, and expertise. Our Software-as-a-Service (“SaaS”) HCM solution automates routine management tasks so frontline leaders can focus on the key elements that drive business performance and employee engagement, such as goal setting, coaching, and talent development. Our comprehensive suite of solutions enables organizations to streamline administrative workflows and achieve regulatory compliance while serving as the single, secure system of record for employee data. Our modern, extensible platform is augmented by industry-specific domain expertise and offers award-winning ease-of-use with an intuitive user experience and deep third-party integrations. As of ~~March~~September 3130, 2024, approximately 3031,~~600~~000 customers across all 50 states trusted us to empower their leaders to ~~build~~drive ~~winning~~business ~~teams~~results.

Our Business Model

Our revenue is almost entirely recurring in nature and largely attributable to the sale of SaaS subscriptions of our cloud-based HCM software platform. We typically generate revenue from customers on a per-employee-per-month (“PEPM”) basis whereby our revenue is derived from the number of employees of a given customer, and the amount, type, and timing of products provided to a customer’s employees. As a result, we increase our recurring revenue as we add more customers and expand our HCM suite and as our customers add more employees and purchase additional product modules. Our subscription-based business model is highly recurring in nature and provides significant visibility into our future operating results. Recurring and other revenues are primarily revenues derived from the provision of our five HCM software bundles and nonrefundable implementation fees, which represented approximately 92% of total revenues for ~~both~~ the three ~~and nine~~ months ended ~~March~~September 3130, 2024. In addition, we earn interest income on funds held for clients.

Our go-to-market strategy consists of a robust organic sales and marketing engine and broad referral network of health insurance and retirement benefits brokers. We primarily market and sell our solutions through a direct sales ~~force~~teams, which is organized into field and inside sales teams based on customer size and geography. In addition, during the ~~nine~~three months ended ~~March 31~~September 30, 2024, we launched anPaycor ~~Embedded~~Compensation ~~HCM~~Management, ~~Solution~~a ~~that~~collaborative ~~expands~~solution purpose-built for leaders who want to streamline compensation planning while engaging and retaining employees and a time management solution and Time-Off Management, a suite of innovative features designed to transform time-off management for the modern workforce. We also continue to expand our distribution model through embedded technology and service partnerships. ~~Our~~Prospective ~~highly~~customers ~~efficient~~are ~~and~~driven ~~multi-pronged go-~~to~~-market~~ ~~strategy~~our iswebsite athrough ~~key~~brand ~~driver~~awareness ofand ~~our~~demand ~~growth~~generation.

2219

The table below sets forth selected results of operations for the three ~~and nine~~ months ended ~~March~~September 3130, 2024 and 2023.

	~~Three Months Ended~~			Three Months Ended			~~Nine Months Ended~~
	March 31,						March 31,
				September 30,
(in thousands)	~~2024~~			~~2023~~			2024			2023
Total Revenues	$	~~187,019~~		$	~~161,482~~		$	~~490~~167,~~148~~476		$	~~412~~143,~~649~~588
Income (Loss) from Operations	$	7,456		$	(8,031)		$	(42,091)		$	(72,990)
Loss from Operations							$	(14,254)		$	(23,372)
Operating Margin	~~4.0~~		%	~~(5.0)~~		%	(8.65)		%	(1716.73)		%
Adjusted Operating Income*	$	~~47,730~~		$	~~39,107~~		$	8622,~~947~~800		$	6715,~~163~~920
Adjusted Operating Income Margin*	~~25.5~~		%	~~24.2~~		%	1713.76		%	1611.31		%
Net Income (Loss)	$	6,193		$	(7,340)		$	(40,652)		$	(63,855)
Net Loss							$	(7,284)		$	(20,596)

*Adjusted Operating Income and Adjusted Operating Income Margin are non-U.S. GAAP (“non-GAAP”) financial measures. See Non-GAAP Financial Measures below for a definition of our non-GAAP measures and reconciliations to the most closely comparable U.S. GAAP measures.

Impact of Adverse Macroeconomic Conditions

Negative macroeconomic conditions, such as supply chain disruptions, labor shortages, extended periods of inflation and rising interest rates, are expected to continue to pose risks to our and our customers’ businesses for the foreseeable future and may impact our business. It is also possible that fiscal or monetary policies adopted in an attempt to curtail the broadening or protracted extension of these negative conditions could lead to an economic slowdown or cause a recession in the U.S. or global economy. Further, bank failures and the follow-on effects of those events may cause instability in the banking industry or result in failures at other banks or financial institutions to which we or our customers may face direct or indirect exposure. If a significant number of our customers are unable to continue as viable businesses or if they significantly reduce headcount in response to these conditions, we or our customers are unable (temporarily or otherwise) to access deposits or utilize existing sources of liquidity, there is a reduction in business confidence and activity, a decrease in government and consumer spending, a decrease in HCM and payroll solutions spending by SMBs, or a decrease in overall domestic production or consumption of goods and services more globally, our business, financial condition, and results of operations could be materially and adversely impacted.

Key Factors Affecting Our Performance

Our historical financial performance has been, and we expect our financial performance in the future to be, driven by our ability to:

Expand Our Sales Footprint to Add New Customers

Our current customer base represents a small portion of the U.S. market for HCM and payroll solutions. We believe there is substantial opportunity to continue to broaden our customer base, particularly in the 1550 most populous metropolitan statistical areas in the United States ~~(i.e.~~, ~~Tier 1 markets),~~ by expanding our sales headcount and Embedded HCM Solution partners. Our ability to do so will depend on several factors, including the ability to recruit and retain qualified sales staff, the effectiveness of our products, the relative pricing of our products, our competitors’ offerings, and the effectiveness of our marketing efforts.

We define a customer as a parent company grouping, which may include multiple subsidiary client accounts with separate taxpayer identification numbers. We also track client accounts as it provides an alternative measure of the scale of our business and customers. We believe the number of customer employees on our platform is a key indicator of the growth of our business. We define customer employees as the number of our customers’ employees at the end of any particular period. As of ~~March~~September 3130, 2024 and 2023, we had approximately 2,~~616~~600,000 and 2,~~396~~500,000 customer employees, respectively, representing a ~~period~~year-over-~~period~~year increase of ~~9.2~~4%. We define a customer as a parent company grouping, which may include multiple subsidiary client accounts with separate taxpayer identification numbers. As of September 30, 2024 and 2023, we had approximately 31,000 customers for both periods.

In addition, we are focused on maintaining and expanding broker relationships to drive the acquisition of new customers through mutual referrals. Insurance and benefits brokers are trusted advisors to ~~SMBs~~mid-market businesses and are often influential in the HCM selection process. Brokers remained an integral part of our sales approach and influenced over 60% of field bookings during the three months ended September 30, 2024.

Increase Product Penetration with Existing and New Customers

In recent years we have increasingly focused our product pricing strategy away from sales of individual products and solutions towards a simplified bundled pricing approach whereby we market multi-product offerings to our customers. We believe our cloud platform and pricing model provides much better value and predictability for our customers and for Paycor. This strategy has enabled us to effectively drive increased product penetration and PEPM growth at the initial point of sale, as well as stronger retention. We define “effective PEPM” as recurring and other revenue for the period divided by the average number of customer employees, which we calculate as the sum of the number of customer employees at the end of each month over the period divided by the total number of months in the period. We intend to advance this strategy by progressively expanding the breadth of features included in our product bundles. In addition to sales to new customers, there is a substantial opportunity within our existing customer base to cross-sell additional products from our portfolio, including Workforce Management, Benefits Administration, Talent Acquisition and Talent Management.

Our ability to successfully increase revenue per customer is dependent upon several factors, including the number of employees working for our customers, the number of products purchased by each of our customers, our customers’ satisfaction with our solutions and support, and our ability to add new products to our suite.

We believe our ability to retain and expand our existing customers’ spending on our solutions is evidenced by our net revenue retention. We define net revenue retention as the current quarterly period recurring revenue for the cohort of customers at the beginning of the prior year quarterly period, divided by the recurring revenue in the prior year reporting period for that same cohort. In calculating the net revenue retention for a period longer than a quarter, such as a fiscal year, we use the weighted average of the retention rates (calculated in accordance with the preceding sentence) for each applicable quarter included in such period.

For the three months ended September 30, 2024, our net revenue retention has continued to trend favorably compared to the three months ended September 30, 2023, driven by strength in cross sales and pricing initiatives.

Ongoing Product Innovation and Optimization

We believe that our product features and functionality are key differentiators of our offerings. We intend to continue to invest in research and development, particularly regarding the functionality of our platform, to sustain and advance our product leadership. For instance, in fiscal year 2019, we acquired Ximble’s scheduling solution and in fiscal year 2020, we released Paycor Analytics. In fiscal year 2021, we launched our compensation management product and a full suite of talent management tools, including performance reviews, one-on-one coaching, objectives and key results and structured goal setting. In fiscal year 2022, we introduced OnDemand Pay, expense management and a Developer Portal to enhance Paycor’s industry-leading interoperability, making it even easier for clients and partners to seamlessly integrate and sync data between HR and third-party systems. We also released a new payroll-based journal reporting platform to simplify complex staffing reporting requirements for nursing facilities and a predictive resignation feature providing leaders with actionable insights to identify the top drivers of employee resignation. In fiscal year 2023, we acquired ~~Talenya’s~~an intelligent candidate sourcing technology, now Paycor Smart Sourcing, and Verb, Inc.’s behavioral science-based ~~microlearning~~micro-learning platform, now part of Paycor Paths, to enhance our industry-leading talent solutions. We also introduced the COR Leadership Framework, empowering organizations to transform frontline managers into effective leaders through the provision of technology and expertise. ~~As a result of these and other product launches, the total list PEPM and customer-perceived value for our full suite of products continues to increase.~~ In fiscal year 2024, we introduced a generative AI analytics digital assistant, powered by Visier, that empowers leaders to quickly and easily consume people-focused analytics in a conversational chat interface. We also introduced ~~pay~~Pay ~~benchmarking~~Benchmarking, which provides market salary insights to enable competitive compensation strategies, and launched ~~labor~~Labor ~~forecasting~~Forecasting, which empowers leaders to right-size their labor costs to their operations by leveraging historical data and demand data forecasts to maximize return on investment and service quality. We launched a new Compensation Management solution, enabling frontline leaders to streamline budgeting and pay cycles. As a result of these and other product launches, the total list PEPM and customer-perceived value for our full suite of products continued to increase. Our ability to innovate and introduce competitive new products is dependent on our ability to recruit and retain top technical talent and invest in research and development initiatives.

Components of Results of Operations

Basis of Presentation

Revenues

Recurring and Other Revenue

We derive our revenue from contractual agreements, which contain recurring and non-recurring service fees. The majority of our contracts are cancellable by the customer on 60 days’ notice ~~or less~~. We recognize revenue when control of the promised goods or services is transferred to customers in an amount that reflects the consideration that we are entitled to for those goods or services. Recurring revenue consists primarily of revenues derived from the provision of our payroll and HR-related cloud-based computing services, Workforce Management, Talent Management, Talent Acquisition and Benefits Administration. The performance obligations related to recurring services are generally satisfied monthly as services are provided, with fees charged and collected based on a PEPM basis. Recurring revenue is generally recognized as the services are provided ~~during~~ each ~~client’s payroll period~~month.

24Other revenue and non-recurring services fees consist mainly of nonrefundable implementation fees, which involve onboarding and configuring the customer within our cloud-based platform. These nonrefundable implementation fees provide certain clients with a material right to renew the contract, with revenue deferred and recognized over the period to which the

Other revenue and non-recurring services fees consist mainly of nonrefundable implementation fees, which involve onboarding and configuring the customer within our cloud-based platform. These nonrefundable implementation fees provide certain clients with a material right to renew the contract, with revenue deferred and recognized over the period to which the material right exists. This is a period of 24 months from finalization of onboarding, which typically concludes within three to six months of the original booking. Deferred revenue also includes an immaterial portion related to recurring subscription services where revenue is recognized over the subscription period. Deferred revenue for these nonrefundable upfront fees and recurring subscription services was $19.9 million as of March 31, 2024, with $5.5 million and $15.3 million of revenue recognized for the three and nine months ended March 31, 2024, respectively. Deferred revenue for these nonrefundable upfront fees and recurring subscription services was $18.4 million as of March 31, 2023, with $4.9 million and $15.1 million of revenue recognized for the three and nine months ended March 31, 2023, respectively. 21

material right exists. This is generally a period of 24 months from finalization of onboarding, which typically concludes within three to six months of the original booking. Deferred revenue also includes an immaterial portion related to recurring subscription services where revenue is recognized over the subscription period. Deferred revenue for these nonrefundable upfront fees and recurring subscription services was $18.7 million for both periods ended September 30, 2024 and 2023, respectively, with $4.8 million of revenue recognized for both the three months ended September 30, 2024 and 2023, respectively.

We defer certain commission costs that meet the capitalization criteria. We also capitalize certain costs to fulfill a contract related to our proprietary products if they are identifiable, generate or enhance resources used to satisfy future performance obligations and are expected to be recovered. We utilize the portfolio approach to account for both the cost of obtaining a contract and the cost of fulfilling a contract.

Capitalized costs to fulfill a contract and cost to obtain a contract are amortized over the expected period of benefit, which is generally six years based on our average client life and other qualitative factors, including rate of technological changes. We do not incur any additional costs to obtain or fulfill contracts upon renewal. We recognize additional selling and commission costs and fulfillment costs when an existing client purchases additional services. The additional costs only relate to the additional services purchased and do not relate to the renewal of previous services. We continue to expense certain costs to obtain a contract and cost to fulfill a contract if those costs do not meet the capitalization criteria.

We expect recurring and other revenue to increase as we continue to add new customer employees and sell additional products to our existing customers.

Interest Income on Funds Held for Clients

We earn interest income on funds held for clients. We generally collect substantially all funds for employee payroll payments and related taxes in advance of remittance to employees and taxing authorities. Prior to remittance to employees and taxing authorities, we generally earn interest on these funds through demand deposit accounts with financial institutions with which we have automated clearinghouse arrangements. We also earn interest by investing a portion of funds held for clients in highly liquid, investment-grade marketable securities. We expect funds held for our clients to generally grow as the employees per customer increase and as we add customers to our platform. Interest income on funds held for clients will fluctuate based on market rates of demand deposit accounts, as well as the highly liquid, investment-grade marketable securities in which we invest the client funds.

Cost of Revenues

Cost of revenues includes costs relating to the provision of ongoing customer support and implementation activities, payroll tax filing, distribution of printed checks and other materials providing our payroll and other HCM solutions. These costs primarily consist of employee-related expenses for associates who service customers, as well as third-party processing fees, delivery costs, hosting costs, and bank fees associated with client fund transfers. Costs for recurring support are generally expensed as incurred, while such costs for onboarding and configuring our products for our customers are capitalized and amortized over a period of six years.

We amortized $910.58 million and $6.8.1 million of capitalized contract fulfillment costs during the three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $26~~.~~5 million~~ ~~and $18.6 million of capitalized contract fulfillment costs during the nine months ended March 31, 2024 and 2023, respectively.~~ We expect to realize increased amortization in future periods as the total capitalized contract fulfillment costs on our balance sheet increases.

We also capitalize a portion of our internal-use software costs including external direct costs of materials and services associated with developing or obtaining internal-use software and certain payroll and payroll-related costs for associates who are directly associated with internal-use software projects, which are then generally amortized over a period of three years into cost of revenues. We amortized $1011.45 million and $89.58 million of capitalized internal-use and acquired software costs during the three months ended September 30, 2024 and 2023, respectively.

25Our cost of revenues is expected to increase in absolute dollars as we expand our customer base. However, in the long-term we expect cost of revenues to reduce as a percentage of total revenues as our business scales.

the three months ended March 31, 2024 and 2023, respectively, and $30.0 million and $24.1 million of capitalized internal-use and acquired software costs during the nine months ended March 31, 2024 and 2023, respectively. 22

Our cost of revenues is expected to increase in absolute dollars as we expand our customer employee base. However, in the long-term we expect cost of revenues to reduce as a percentage of total revenues as our business scales.

Operating Expenses

Sales and Marketing

Sales and marketing expenses consist primarily of employee-related expenses for our direct sales and marketing staff, marketing, advertising and promotion expenses, including amortization expense associated with the exclusive naming rights to Paycor Stadium (the “Naming Rights”), home to the Cincinnati Bengals since 2000, and other related costs. We capitalize certain commission costs related to new contracts or purchases of additional services by our existing customers and amortize such items over a period of six years.

We amortized $78.~~1 million and $5.3 million of capitalized contract acquisition costs during the three months ended March 31, 2024 and 2023, respectively, and $20.~~0 million and $~~14.~~6.2 million of capitalized contract acquisition costs during the ~~nine months ended March 31, 2024 and 2023, respectively. Additionally, we recorded $1.1 million and $0.8 million of amortization expense associated with the Naming Rights during the~~ three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $3~~.2 ~~million and $2.8 million of amortization expense associated with the Naming Rights during the nine months ended March 31, 2024 and 2023, respectively.~~ We expect to realize increased amortization in future periods as the total capitalized contract acquisition costs on our balance sheet increases.

We seek to grow our number of ~~customer~~new ~~employees~~customers and upsell existing customers, and therefore our sales and marketing expenses are expected to continue to increase in absolute dollars as we grow our sales organization and expand our marketing activities.

General and Administrative

General and administrative expenses consist primarily of employee-related costs for our administrative, finance, accounting, legal, enterprise technology and human resources departments. Additional expenses include consulting and professional fees, occupancy costs, insurance, and other corporate expenses.

We amortized $2221.18 million and $2223.43 million of intangible assets, excluding acquired software amortized through cost of revenues and the Naming Rights amortized through sales and marketing ~~expenses~~, during the three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $68~~.7 million and $65.8 million of intangible assets, excluding acquired software amortized through cost of revenues and the Naming Rights amortized through sales and marketing, during the nine months ended March 31, 2024 and 2023, respectively. The period-to-period changes are driven by the remaining amortizable life of the underlying intangible assets from multiple acquisitions.

We expect our general and administrative expenses to increase in absolute dollars as we grow and scale our business.

Research and Development

Research and development expenses consist primarily of employee-related expenses for our software development and product management staff. Additional expenses include costs related to the development, maintenance, quality assurance and testing of new technologies, and ongoing refinement of our existing solutions. Research and development expenses, other than internal-use software costs qualifying for capitalization, including costs associated with preliminary project stage activities, training, maintenance, and all other post-implementation stage activities are expensed as incurred.

We capitalize a portion of our development costs related to internal-use software, which are amortized over a period of three years into cost of revenues. The timing of our capitalized development projects may affect the amount of development costs expensed in any given period. The table below sets forth the amounts of capitalized and expensed research and development costs for the following periods:


	Three Months Ended
	September 30,
(in thousands)		2024		2023
Capitalized software		$	12,710	$	12,558
Research and development expenses		$	17,428	$	14,055

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
(in thousands)	2024		2023		2024		2023
Capitalized software	$	12,328	$	10,956	$	36,356	$	28,698
Research and development expenses	$	15,067	$	13,658	$	45,787	$	39,935

We expect to increase our research and development expenses in absolute dollars as we continue to broaden our product offerings and extend our technological leadership by investing in the development of new technologies and introducing them to new and existing customers.

Interest Expense

Interest expense consists primarily of interest payments and accruals relating to outstanding borrowings as well as accretion expense associated with the Naming Rights liability. We expect interest expense to vary each reporting period depending on the amount of outstanding borrowings and prevailing interest rates.

Other Income (Expense)

Other income (expense) generally consists of other income and expense items outside of our normal operations, such as interest income on operating cash, realized gains or losses on the sale of certain positions of funds held for clients, change in fair value of contingent consideration, gains or losses on the extinguishment of debt and expenses relating to our financing arrangements.

Results of Operations

The following table sets forth our unaudited condensed consolidated statements of operations for the periods indicated.

~~Three Months Ended~~

Three Months Ended

~~Nine Months Ended~~

(in thousands)

~~March 31, 2024~~

~~March 31, 2023~~

~~March~~September 3130, 2024

~~March~~September 3130, 2023

Consolidated Statement of Operations Data:

Revenues:

Recurring and other revenue

~~171,973~~

~~150,757~~

~~451~~153,~~913~~999

~~389~~132,~~908~~708

Interest income on funds held for clients

~~15,046~~

~~10,725~~

3813,~~235~~477

2210,~~741~~880

Total revenues

~~187,019~~

~~161,482~~

~~490~~167,~~148~~476

~~412~~143,~~649~~588

Cost of revenues

~~58,736~~

~~49,323~~

~~165~~59,~~239~~217

~~138~~51,~~692~~378

Gross profit

~~128,283~~

~~112,159~~

~~324~~108,~~909~~259

~~273~~92,~~957~~210

Operating expenses:

Sales and marketing

~~55,839~~

~~55,499~~

~~166~~56,~~370~~789

~~155~~52,~~607~~778

General and administrative

~~49,921~~

~~51,033~~

~~154~~48,~~843~~296

~~151~~48,~~405~~749

Research and development

~~15,067~~

~~13,658~~

4517,~~787~~428

3914,~~935~~055

Total operating expenses

~~120,827~~

~~120,190~~

~~367~~122,~~000~~513

~~346~~115,~~947~~582

Income (loss) from operations

7,456

(8,031)

(42,091)

(72,990)

Loss from operations

(14,254)

(23,372)

Interest expense

~~(1,146)~~

~~(1,970)~~

(31,~~543~~138)

(31,~~461~~244)

Other income

~~1,133~~

~~2,003~~

~~319~~1,670

~~2,514~~931

Income (loss) before expense (benefit) for income taxes

7,443

(7,998)

(45,315)

(73,937)

Loss before benefit for income taxes

(13,722)

(23,685)

Income tax expense (benefit)

1,250

(658)

(4,663)

(10,082)

Income tax benefit

(6,438)

(3,089)

Net income (loss)

6,193

(7,340)

(40,652)

(63,855)

Net loss

(7,284)

(20,596)

27Comparison of the Three Months Ended September 30, 2024 and September 30, 2023

Comparison of the Three Months Ended March 31, 2024 and March 31, 2023

Revenues

Three Months Ended

(in thousands)

~~March~~September 3130, 2024

~~March~~September 3130, 2023

$ Change

% Change

Revenues:

Recurring and other revenue

~~171~~153,~~973~~999

~~150~~132,~~757~~708

21,~~216~~291

1416

Interest income on funds held for clients

1513,~~046~~477

10,~~725~~880

42,~~321~~597

4024

Total revenues

~~187~~167,~~019~~476

~~161~~143,~~482~~588

2523,~~537~~888

1617

Total revenues for the three months ended March 31, 2024 and 2023 were $187.0 million and $161.5 million, respectively. For the three months ended March 31, 2024 and 2023, recurring and other revenue accounted for $172.0 million and $150.8 million, respectively, of total revenues. Additionally, interest income on funds held for clients accounted for $15.0 million and $10.7 million, respectively, for the three months ended March 31, 2024 and 2023. Total revenues increased over the prior year period primarily as a result of an increase in customer employees and effective PEPM, driving $14.0 million and $7.2 million of increased revenue, respectively, as well as a $4.3 increase in interest income on funds held for clients.24

~~Interest~~Total ~~income~~revenues onfor ~~funds~~the ~~held~~three ~~for~~months ~~clients~~ended ~~increased~~September 30, ~~primarily~~2024 asand a2023 ~~result~~were of$167.5 ~~higher~~million ~~average~~and ~~daily~~$143.6 million, ~~balances~~respectively. ~~for~~For ~~funds~~the ~~held~~three ~~due~~months toended ~~the~~September 30, ~~addition~~2024 ofand ~~customer~~2023, ~~employees~~recurring and ~~higher~~other ~~average~~revenue ~~interest~~accounted ~~rates~~for ~~across~~$154.0 ~~our~~million ~~portfolio~~and $132.7 million, respectively, of ~~debt-security~~total ~~investments~~revenues. ~~Average~~Additionally, ~~client~~interest income on funds ~~balances~~held for clients accounted for $13.5 million and $10.9 million, respectively, for the three months ended ~~March~~September 3130, 2024 and 2023. ~~were~~Total $1revenues increased over the prior year period primarily as a result of an increase in effective PEPM and in the customer employees,~~271~~ driving $15.12 million and $~~1,166~~6.1 million of increased revenue, respectively, as well as a $2.6 million increase in interest income on funds held for clients.

Interest income on funds held for clients increased primarily as a result of higher average daily balances for funds held due to the addition of customer employees and higher average interest rates across our portfolio of debt-security investments. Average client funds balance for the three months ended September 30, 2024 and 2023 were $1,103.7 million and $1,016.8 million, respectively.

Cost of Revenues

	Three Months Ended
(in thousands)	~~March~~September 3130, 2024			~~March~~September 3130, 2023			$ Change		% Change
Cost of revenues	$	5859,~~736~~217		$	4951,~~323~~378		$	97,~~413~~839	1915	%
Percentage of total revenues	3135		%	3136		%
Gross profit	$	~~128~~108,~~283~~259		$	~~112~~92,~~159~~210		$	16,~~124~~049	1417	%
Percentage of total revenues	6965		%	6964		%

Total cost of revenues for the three months ended ~~March~~September 3130, 2024 and 2023 were $5859.72 million and $4951.34 million, respectively. ~~Our~~Total ~~total~~ cost of revenues increased primarily as a result of a $2.7 million increase in amortization of deferred contract costs, a $2.52 million increase in amortization expense relating to capitalized software, a $21.28 million increase in employee-related costs to support new customers, including a $0.81 million decrease in stock-based compensation expense, and a $0.75 million increase in licensing fees.

Operating Expenses

Sales and Marketing

	Three Months Ended
(in thousands)	~~March~~September 3130, 2024			~~March~~September 3130, 2023			$ Change		% Change
Sales and marketing	$	5556,~~839~~789		$	5552,~~499~~778		$	~~340~~4,011	18	%
Percentage of total revenues	3034		%	3437		%

Sales and marketing expenses for the three months ended ~~March~~September 3130, 2024 and 2023 were $5556.8 million and $5552.58 million, respectively. The increase in sales and marketing expenses was primarily the result of a $1.8 million increase in amortization expense associated with costs to obtain a contract, a $1.6 million increase in employee-related costs, including a $0.1 million decrease in stock-based compensation expense and a $0.47 million increase in amortization expense associated with advertising expenses.

with the Naming Rights Agreement and advertising expenses, partially offset by a $1.3 million decrease in employee-related costs, including a $3.5 million decrease in stock-based compensation expense.

General and Administrative

	Three Months Ended
(in thousands)	~~March~~September 3130, 2024			~~March~~September 3130, 2023			$ Change		% Change
General and administrative	$	4948,~~921~~296		$	5148,~~033~~749		$	(~~1,112~~453)	(21)	%
Percentage of total revenues	2729		%	3234		%

General and administrative expenses for the three months ended March 31, 2024 and 2023 were $49.9 million and $51.0 million, respectively. The decrease in general and administrative expenses was primarily driven by a $0.8 million decrease in loss from exiting leases of certain facilities and a $0.7 million decrease in employee-related costs, including a $1.1 million decrease in stock-based compensation expense.25

General and administrative expenses for the three months ended September 30, 2024 and 2023 were $48.3 million and $48.7 million, respectively. The decrease in general and administrative expenses was primarily driven by a $0.4 million decrease in employee-related costs, including a $0.3 million decrease in stock-based compensation expense.

Research and Development

	Three Months Ended
(in thousands)	~~March~~September 3130, 2024			~~March~~September 3130, 2023			$ Change		% Change
Research and development	$	1517,~~067~~428		$	1314,~~658~~055		$	13,~~409~~373	1024	%
Percentage of total revenues	810		%	810		%

Research and development expenses for the three months ended ~~March~~September 3130, 2024 and 2023 were $1517.14 million and $1314.71 million, respectively. The increase in research and development expenses was primarily the result of a $12.19 million increase in employee-related costs, including a $0.13 million ~~decrease~~increase in stock-based compensation expense, and a $0.63 million increase in ~~licensing~~professional services, consulting fees and other costs.

Interest Expense

Three Months Ended

(in thousands)

~~March~~September 3130, 2024

~~March~~September 3130, 2023

$ Change

% Change

Interest expense

1,~~146~~138

1,~~970~~244

(~~824~~106)

(429)

Percentage of total revenues

<1 %

<21 %

Interest expense for both of the three months ended ~~March~~September 3130, 2024 and 2023 was $1.1 million and $21.0 2 million, respectively. Interest expense primarily ~~consists~~consisted of accretion expense associated with the Naming Rights Agreement.

Other income

Three Months Ended

(in thousands)

~~March~~September 3130, 2024

~~March~~September 3130, 2023

$ Change

% Change

Other income

1,~~133~~670

~~2,003~~931

~~(870)~~739

~~(43)~~79

Other income for the three months ended ~~March~~September 3130, 2024 and 2023 was $1.17 million and $2.0.9 million, respectively. Other income ~~during~~for the three months ended ~~March~~September 3130, 2024 primarily consisted of interest income earned on operating cash, partially offset by the change in fair value of the contingent consideration related to the October 2022 acquisition of Talenya Ltd, an Israeli-based provider of an AI-driven solution for talent sourcing and recruitment (the “Talenya Acquisition”). Other income for the three months ended September 30, 2023 primarily ~~consists~~consisted of interest income earned on operating cash.

Income tax expense (benefit)

Income tax expense for the three months ended March 31, 2024 was $1.3 million, reflecting an effective income tax rate for the current period of 17.2%. Income tax benefit for the three months ended March 31, 2023 was $0.7 million, reflecting

an effective income tax rate for the prior year period of 8.2%. The change in income tax expense (benefit) was primarily related to a lower loss before benefit for income taxes recognized for the current period and an increase in expense related to executive compensation for which no income tax benefit can be recognized for the current period, partially offset by an increase in tax deductible stock-based compensation expense for the current period.

Comparison of the Nine Months Ended March 31, 2024 and March 31, 2023

Revenues

	Nine Months Ended
(in thousands)	March 31, 2024		March 31, 2023		$ Change		% Change
Revenues:
Recurring and other revenue	$	451,913	$	389,908	$	62,005	16	%
Interest income on funds held for clients	38,235		22,741		15,494		68
Total revenues	$	490,148	$	412,649	$	77,499	19	%

Total revenues for the nine months ended March 31, 2024 and 2023 were $490.1 million and $412.6 million, respectively. For the nine months ended March 31, 2024 and 2023, recurring and other revenue accounted for $451.9 million and $389.9 million, respectively, of total revenues. Additionally, interest income on funds held for clients accounted for $38.2 million and $22.7 million, respectively, for the nine months ended March 31, 2024 and 2023. Total revenues increased over the prior year period primarily as a result of an increase in customer employees and effective PEPM, driving $37.2 million and $24.8 million of increased revenue, respectively, as well as a $15.5 million increase in interest income on funds held for clients.

Interest income on funds held for clients increased primarily as a result of higher average daily balances for funds held due to the addition of customer employees and higher average interest rates across our portfolio of debt-security investments. Average client funds balance for the nine months ended March 31, 2024 and 2023 were $1,126.4 million and $1,034.5 million, respectively.

Cost of Revenues

	Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			$ Change		% Change
Cost of revenues	$	165,239		$	138,692		$	26,547	19	%
Percentage of total revenues	34		%	34		%
Gross profit	$	324,909		$	273,957		$	50,952	19	%
Percentage of total revenues	66		%	66		%

Total cost of revenues for the nine months ended March 31, 2024 and 2023 were $165.2 million and $138.7 million, respectively. Our total cost of revenues increased primarily as a result of a $7.9 million increase in amortization of deferred contract costs, a $7.0 million increase in employee-related costs to support new customers, including a $1.1 million decrease in stock-based compensation expense, a $6.9 million increase in amortization expense relating to capitalized software and a $2.0 million increase in licensing fees.

Operating Expenses

Sales and Marketing

	Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			$ Change		% Change
Sales and marketing	$	166,370		$	155,607		$	10,763	7	%
Percentage of total revenues	34		%	38		%

Sales and marketing expenses for the nine months ended March 31, 2024 and 2023 were $166.4 million and $155.6 million, respectively. The increase in sales and marketing expenses was primarily the result of a $5.4 million increase in amortization expense associated with costs to obtain a contract, a $3.2 million increase in amortization expense associated with the Naming Rights and advertising expenses, and a $2.7 million increase in employee-related costs, including a $8.1 million decrease in stock-based compensation expense.

General and Administrative

	Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			$ Change		% Change
General and administrative	$	154,843		$	151,405		$	3,438	2	%
Percentage of total revenues	32		%	37		%

General and administrative expenses for the nine months ended March 31, 2024 and 2023 were $154.8 million and $151.4 million, respectively. The increase in general and administrative expenses was primarily driven by a $5.6 million increase in employee-related costs, including a $1.3 million increase in stock-based compensation expense, a $2.9 million increase in intangible amortization expense primarily associated with asset acquisitions, including the capitalization of contingent payments, and a $0.8 million increase in licensing fees, partially offset by a $4.0 million decrease in professional services, consulting fees and other costs and a $1.7 million decrease in loss from exiting leases of certain facilities.

Research and Development

	Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			$ Change		% Change
Research and development	$	45,787		$	39,935		$	5,852	15	%
Percentage of total revenues	9		%	10		%

Research and development expenses for the nine months ended March 31, 2024 and 2023 were $45.8 million and $39.9 million, respectively. The increase in research and development expenses was primarily the result of a $4.1 million increase in employee-related costs, including a $0.6 million increase in stock-based compensation, and a $2.0 million increase in licensing fees.

Interest Expense

	Nine Months Ended
(in thousands)	March 31, 2024		March 31, 2023		$ Change		% Change
Interest expense	$	3,543	$	3,461	$	82	2	%
Percentage of total revenues	<1 %		<1 %

Interest expense for both of the nine months ended March 31, 2024 and 2023 was $3.5 million. Interest expense primarily consisted of accretion expense associated with the Naming Rights Agreement.

Other income

	Nine Months Ended
(in thousands)	March 31, 2024		March 31, 2023		$ Change		% Change
Other income	$	319	$	2,514	$	(2,195)	(87)	%

Other income for the nine months ended March 31, 2024 and 2023 was $0.3 million and $2.5 million, respectively. Other income for the nine months ended March 31, 2024 primarily consisted of interest income earned on operating cash,

partially offset by the change in fair value of the contingent consideration related to the acquisition of Talenya. Other income for the nine months ended March 31, 2023 primarily consisted of interest income earned on operating cash.

Income tax benefit

Income tax benefit for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023 was $46.74 million and $103.1 million, respectively, reflecting effective tax rates for those periods of 1046.39% and 13.60%, respectively. The ~~decrease~~increase in income tax benefit is primarily related to a lower loss before benefit for income taxes recognized for the current period and ana ~~increase~~valuation inallowance ~~expense~~primarily ~~related~~driven ~~to executive compensation for which no income tax benefit can be recognized for the current period, partially offset~~ by anInternal ~~increase~~Revenue inCode ~~tax~~Section ~~deductible~~174 ~~stock-based~~amortization ~~compensation~~of ~~expense~~research ~~for~~and ~~the~~development ~~current period~~expenses.

Non-GAAP Financial Measures

In addition to our results determined in accordance with U.S. GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with our past financial performance and assists in comparisons with other companies, some of which may use similar non-GAAP financial ~~information~~measures to supplement their U.S. GAAP results. The non-GAAP financial information is presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with U.S. GAAP and may be different from similarly titled non-GAAP measures used by other companies. A reconciliation is provided below for each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with U.S. GAAP. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures.

Adjusted Gross Profit and Adjusted Gross Profit Margin

We define Adjusted Gross Profit as gross profit before amortization of intangible assets, stock-based compensation expense, and other certain corporate expenses, in each case that are included in costs of ~~recurring~~ revenues. We define Adjusted Gross Profit Margin as Adjusted Gross Profit divided by total revenues.

We use Adjusted Gross Profit and Adjusted Gross Profit Margin to understand and evaluate our core operating performance and trends. We believe these metrics are useful measures to us and to our investors to assist in evaluating our core operating performance because it provides consistency and direct comparability with our past financial performance and between fiscal periods, as the metrics eliminate the effects of variability of items, such as stock-based compensation expense and amortization of intangible assets, which are non-cash expenses that may fluctuate for reasons unrelated to overall operating performance.

Adjusted Gross Profit and Adjusted Gross Profit Margin have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP and should not be considered as replacements for gross profit and gross profit margin, as determined by U.S. GAAP, or as measures of our profitability. We compensate for these limitations by relying primarily on our U.S. GAAP results and using non-GAAP measures only for supplemental purposes.

Adjusted Gross Profit was $~~130~~110.7 million and $~~116~~95.02 million, or 6966.91% and 7166.~~8% of total revenue, for the three months ended March 31, 2024 and 2023, respectively. Adjusted Gross Profit was $333.~~3 ~~million and $284.5 million, or 68.0~~% ~~and 68.9%~~ of total revenues, for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023, respectively. Adjusted Gross Profit increased for the three ~~and nine~~ months ended ~~March~~September 3130, 2024, primarily driven by the increase in ~~revenue~~total revenues from employee customer growth, partially offset by additional employee-related costs to support new customers, amortization of costs to fulfill contracts within cost of revenues and amortization of capitalized software.


	Three Months Ended
(in thousands)		September 30, 2024			September 30, 2023
Gross Profit*		$	108,259		$	92,210
Gross Profit Margin		64.6		%	64.2		%
Amortization of intangible assets		875			1,375
Stock-based compensation expense		1,502			1,595

Corporate adjustments		21			—
Adjusted Gross Profit*		$	110,657		$	95,180
Adjusted Gross Profit Margin		66.1		%	66.3		%

	Three Months Ended						Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			March 31, 2024			March 31, 2023
Gross Profit*	$	128,283		$	112,159		$	324,909		$	273,957
Gross Profit Margin	68.6		%	69.5		%	66.3		%	66.4		%
Amortization of intangible assets	740			1,358			2,749			3,786
Stock-based compensation expense	1,677			2,440			5,676			6,755
Adjusted Gross Profit*	$	130,700		$	115,957		$	333,334		$	284,498
Adjusted Gross Profit Margin	69.9		%	71.8		%	68.0		%	68.9		%

* Gross Profit and Adjusted Gross Profit were burdened by depreciation expense of $0.6 million for both the three months ended September 30, 2024 and 2023. Gross Profit and Adjusted Gross Profit were burdened by amortization of capitalized software of $10.6 million and $8.5 million for the three months ended September 30, 2024 and 2023, respectively. Gross Profit and Adjusted Gross Profit were burdened by amortization of deferred contract costs of $10.8 million and $8.1 million for the three months ended September 30, 2024 and 2023, respectively.

* Gross Profit and Adjusted Gross Profit were burdened by depreciation expense of $0.6 million and $0.4 million for the three months ended March 31, 2024 and 2023, respectively, and $1.7 million and $1.3 million for the nine months ended March 31, 2024 and 2023, respectively. Gross Profit and Adjusted Gross Profit were burdened by amortization of capitalized software of $9.6 million and $7.2 million for the three months ended March 31, 2024 and 2023, respectively, and $27.3 million and $20.3 million for the nine months ended March 31, 2024 and 2023, respectively. Gross Profit and Adjusted Gross Profit are burdened by amortization of deferred contract costs of $9.5 million and $6.8 million for the three months ended March 31, 2024 and 2023, respectively, and $26.5 million and $18.6 million for the nine months ended March 31, 2024 and 2023, respectively.

Adjusted Operating Income

We define Adjusted Operating Income as income (loss) from operations before amortization of acquired intangible assets and Naming Rights, stock-based compensation expense, exit costs due to exiting leases of certain facilities and ~~other~~ certain other corporate expenses, such as costs related to ~~acquisitions~~secondary offerings by our controlling stockholder, professional, consulting and other costs associated with strategic initiatives and transaction expenses. We define Adjusted Operating Income Margin as Adjusted Operating Income divided by total revenues.

We use Adjusted Operating Income and Adjusted Operating Income Margin to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget, and to develop short-term and long-term operating plans. We believe that Adjusted Operating Income and Adjusted Operating Income Margin facilitate comparison of our operating performance on a consistent basis between periods, and when viewed in combination with our results prepared in accordance with U.S. GAAP, help provide a broader picture of factors and trends affecting our results of operations. While the amortization expense relating to intangible assets is excluded from Adjusted Operating Income, the revenue related to such intangible assets is reflected in Adjusted Operating Income as these assets contribute to our revenue generation.

Adjusted Operating Income and Adjusted Operating Income Margin have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under U.S. GAAP. Because of these limitations, Adjusted Operating Income and Adjusted Operating Income Margin should not be considered as replacements for operating income (loss) and operating income (loss) margin, as determined by U.S. GAAP, or as measures of our profitability. We compensate for these limitations by relying primarily on our U.S. GAAP results and using non-GAAP measures only for supplemental purposes.

Adjusted Operating Income was $4722.78 million and $3915.19 million for the three months ended ~~March~~September 3130, 2024 and 2023, respectively. Adjusted Operating Income ~~was $86.9 million and $67.2 million for the nine months ended March 31, 2024 and 2023, respectively. Adjusted Operating Income~~ increased for the three ~~and nine~~ months ended ~~March~~September 3130, 2024, primarily driven by anthe increase in total revenues, partially offset by continued investment in employee-related costs to support new customers, expand our sales coverage, and develop our products, as well as increased amortization related to deferred contract costs and capitalized software.


	Three Months Ended
(in thousands)		September 30, 2024			September 30, 2023
Loss from Operations		$	(14,254)		$	(23,372)
Operating Margin		(8.5)		%	(16.3)		%
Amortization of intangible assets		23,696			25,710
Stock-based compensation expense		12,665			12,915

Loss (gain) on lease exit*		6			(144)
Corporate adjustments**		687			811
Adjusted Operating Income		$	22,800		$	15,920
Adjusted Operating Income Margin		13.6		%	11.1		%

	Three Months Ended						Nine Months Ended
(in thousands)	March 31, 2024			March 31, 2023			March 31, 2024			March 31, 2023
Income (loss) from Operations	$	7,456		$	(8,031)		$	(42,091)		$	(72,990)
Operating Margin	4.0		%	(5.0)		%	(8.6)		%	(17.7)		%
Amortization of intangible assets	23,935			24,467			74,608			72,410
Stock-based compensation expense	14,849			20,384			50,813			58,019
Loss (gain) on lease exit*	5			915			(24)			1,733
Corporate adjustments**	1,485			1,372			3,641			7,991
Adjusted Operating Income	$	47,730		$	39,107		$	86,947		$	67,163
Adjusted Operating Income Margin	25.5		%	24.2		%	17.7		%	16.3		%

* Represents exit costs due to exiting leases of certain facilities.

** Corporate adjustments for the three ~~and nine~~ months ended ~~March~~September 3130, 2024 relate to costs associated with the secondary offering completed in March 2024 (“March 2024 Secondary Offering”) and December 2023 (“December 2023 Secondary Offering”) of $0.9 million and $1.5 million, respectively, and professional, consulting, and other costs ofassociated ~~$0.6~~with ~~million~~strategic ~~and~~initiatives of $20.17 million~~, respectively~~. Corporate adjustments for the three ~~and nine~~ months ended ~~March~~September 3130, 2023 relate to costs associated with secondary offerings completed in December 2022 (“December 2022 Secondary Offering”) and September 2022 (“September 2022 Secondary Offering”) of $— million and $2.2 million, respectively, professional, consulting, and other costs ofassociated ~~$1.0~~with ~~million~~strategic ~~and~~initiatives ~~$3.5 million, respectively, and transaction expenses and other costs~~ of $0.48 million ~~and $2~~.~~3 million, respectively.~~

Adjusted Operating Expenses

We define Adjusted Sales and Marketing ~~expense~~expenses as sales and marketing expenses before amortization of Naming Rights, and allocated stock-based compensation expense ~~and other certain corporate expenses~~. We define Adjusted General and Administrative ~~expense~~expenses as general and administrative expenses before amortization of acquired intangible assets, allocated stock-based compensation expense, exit costs due to exiting leases of certain facilities and ~~other~~ certain other corporate expenses., Wesuch ~~define~~as ~~Adjusted~~costs ~~Research~~related ~~and~~to ~~Development~~secondary ~~expense~~offerings asby ~~research~~our ~~and~~controlling ~~development~~stockholder, ~~expenses~~professional, ~~before~~consulting ~~stock-based~~and ~~compensation~~other ~~expense~~costs ~~and~~associated ~~other~~with ~~certain~~strategic ~~corporate~~initiatives ~~expenses.~~and transaction

We use Adjusted Sales and Marketing expense, Adjusted General and Administrative expense and Adjusted Research and Development expense (collectively, “Adjusted Operating Expenses”) to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget, and to develop short-term and long-term operating plans. We believe that Adjusted Operating Expenses facilitate comparison of our operating performance on a consistent basis between periods, and when viewed in combination with our results prepared in accordance with U.S. GAAP, help provide a broader picture of factors and trends affecting our results of operations. 28

expenses. We define Adjusted Research and Development expenses as research and development expenses before allocated stock-based compensation expense.

We use Adjusted Sales and Marketing expenses, Adjusted General and Administrative expenses and Adjusted Research and Development expenses (collectively, “Adjusted Operating Expenses”) to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget, and to develop short-term and long-term operating plans. We believe that Adjusted Operating Expenses facilitate comparison of our operating performance on a consistent basis between periods, and when viewed in combination with our results prepared in accordance with U.S. GAAP, help provide a broader picture of factors and trends affecting our results of operations.

Adjusted Operating Expenses have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under U.S. GAAP. Because of these limitations, Adjusted Operating Expenses should not be considered as replacements for operating expenses, as determined by U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using non-GAAP measures only for supplemental purposes.

Adjusted Sales and Marketing ~~expense~~expenses ~~was~~were $5051.05 million and $4647.4 million for the three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $146~~.9 ~~million and $128.4 million for the nine months ended March 31, 2024 and 2023, respectively.~~ Adjusted Sales and Marketing ~~expense~~expenses increased for the three ~~and nine~~ months ended ~~March~~September 3130, 2024, primarily driven by expanding our sales coverage, an increase in advertising expense, ~~and~~ an increase in amortization of costs to obtain contracts and an increase in licensing fees.

Adjusted General and Administrative ~~expense~~expenses ~~was~~were $2021.21 million and $19.27 million for the three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $61~~.5 ~~million and $56.1 million for the nine months ended March 31, 2024 and 2023, respectively.~~ Adjusted General and Administrative ~~expense~~expenses increased for the three ~~and nine~~ months ended ~~March~~September 3130, 2024, primarily driven by anadditional ~~increase in employee-related costs and an increase in~~ licensing fees.

Adjusted Research and Development ~~expense~~expenses ~~was~~were $1215.72 million and $1112.21 million for the three months ended ~~March~~September 3130, 2024 and 2023, respectively~~, and $38~~.1 ~~million~~Adjusted Research and ~~$32.8 million~~Development expenses increased for the ~~nine~~three months ended ~~March~~September 3130, 2024, primarily driven by an increase in employee-related costs and an increase in professional services cost associated with strategic initiatives.


	Three Months Ended
(in thousands)		September 30, 2024		September 30, 2023
Sales and Marketing expenses		$	56,789	$	52,778
Amortization of intangible assets		(1,059)		(1,059)

Stock-based compensation expense		(4,185)		(4,318)


Adjusted Sales and Marketing expenses		$	51,545	$	47,401
General and Administrative expenses		$	48,296	$	48,749
Amortization of intangible assets		(21,762)		(23,276)
Stock-based compensation expense		(4,786)		(5,072)

(Loss) gain on lease exit*		(6)		144
Corporate adjustments**		(666)		(811)
Adjusted General and Administrative expenses		$	21,076	$	19,734
Research and Development expenses		$	17,428	$	14,055

Stock-based compensation expense		(2,192)		(1,930)


Adjusted Research and Development expenses		$	15,236	$	12,125

2023, respectively. Adjusted Research and Development expense increased for the three and nine months ended March 31, 2024, primarily driven by an increase in employee-related costs and an increase in licensing fees.

	Three Months Ended				Nine Months Ended
(in thousands)	March 31, 2024		March 31, 2023		March 31, 2024		March 31, 2023
Sales and Marketing expense	$	55,839	$	55,499	$	166,370	$	155,607
Amortization of intangible assets	(1,059)		(756)		(3,176)		(2,823)
Stock-based compensation expense	(4,783)		(8,311)		(16,325)		(24,408)
Adjusted Sales and Marketing expense	$	49,997	$	46,432	$	146,869	$	128,376
General and Administrative expense	$	49,921	$	51,033	$	154,843	$	151,405
Amortization of intangible assets	(22,136)		(22,353)		(68,684)		(65,801)
Stock-based compensation expense	(6,059)		(7,168)		(21,082)		(19,765)
(Loss) gain on lease exit*	(5)		(915)		24		(1,733)
Corporate adjustments**	(1,485)		(1,372)		(3,641)		(7,991)
Adjusted General and Administrative expense	$	20,236	$	19,225	$	61,460	$	56,115
Research and Development expense	$	15,067	$	13,658	$	45,787	$	39,935
Stock-based compensation expense	(2,330)		(2,465)		(7,730)		(7,091)
Adjusted Research and Development expense	$	12,737	$	11,193	$	38,057	$	32,844

* Represents exit costs due to exiting leases of certain facilities.

** Corporate adjustments for the three ~~and nine~~ months ended ~~March~~September 3130, 2024 relate to ~~costs associated with the March 2024 Secondary Offering and December 2023 Secondary Offering of $0.9 million and $1.5 million, respectively, and~~ professional, consulting, and other costs ofassociated ~~$0.6~~with ~~million~~strategic ~~and~~initiatives of $20.17 million~~, respectively~~. Corporate adjustments for the three ~~and nine~~ months ended ~~March~~September 3130, 2023 relate to ~~costs associated with the December 2022 Secondary Offering and the September 2022 Secondary Offering of $— million and $2.2 million, respectively,~~ professional, consulting, and other costs ofassociated ~~$1.0~~with ~~million~~strategic ~~and~~initiatives ~~$3.5 million, respectively, and transaction expenses and other costs~~ of $0.48 million ~~and $2~~.~~3 million, respectively.~~

~~Adjusted Net Income and Adjusted Net Income Per Share~~29

~~We define~~ Adjusted Net Income asAttributable income (loss) before expense (benefit) for income tax after adjusting for amortization of acquired intangible assets and Naming Rights, accretion expense associated with the Naming Rights, stock-based compensation expense, gain or loss on the extinguishment of debt, change in fair value of contingent consideration, exit costs due to ~~exiting~~Paycor ~~leases of certain facilities and other certain corporate expenses~~HCM, ~~such as costs related to acquisitions, all of which are tax effected by applying an adjusted effective income tax rate~~Inc. Weand ~~define~~ Adjusted Net Income ~~Per~~Attributable ~~Share~~to asPaycor ~~Adjusted~~HCM, ~~Net Income divided by adjusted shares outstanding~~Inc. ~~Adjusted~~Per ~~shares outstanding includes potentially dilutive securities excluded from the U.S. GAAP dilutive net loss per share calculation.~~Share

We ~~use~~define Adjusted Net Income ~~and~~Attributable ~~Adjusted~~to ~~Net~~Paycor ~~Income~~HCM, ~~Per~~Inc. ~~Share~~as toincome ~~understand~~(loss) ~~and~~before ~~evaluate~~expense ~~our~~(benefit) ~~core~~for ~~operating~~income ~~performance~~tax ~~and~~after ~~trends,~~adjusting tofor ~~prepare~~amortization ~~and~~of ~~approve~~acquired ~~our~~intangible ~~annual~~assets ~~budget~~and Naming Rights, ~~and~~accretion toexpense ~~develop~~associated ~~short-term~~with ~~and~~the ~~long-term~~Naming ~~operating~~Rights, ~~plans.~~stock-based Wecompensation ~~believe~~expense, ~~that~~change ~~Adjusted~~in ~~Net~~fair ~~Income~~value ~~and~~of ~~Adjusted~~contingent ~~Net~~consideration, ~~Income~~exit ~~Per~~costs ~~Share~~due ~~facilitate~~to ~~comparison~~exiting leases of ~~our~~certain ~~operating~~facilities ~~performance~~and oncertain aother ~~consistent~~corporate ~~basis~~expenses, ~~between~~such ~~periods,~~as ~~and~~costs ~~when~~related ~~viewed~~to insecondary ~~combination~~offerings ~~with~~by our ~~results~~controlling ~~prepared~~stockholder, inprofessional, ~~accordance~~consulting, and other costs associated with ~~U.S.~~strategic ~~GAAP~~initiatives and transaction expenses, ~~help~~all ~~provide~~of awhich ~~broader~~are ~~picture~~tax ofeffected ~~factors~~by ~~and~~applying ~~trends~~an ~~affecting~~adjusted ~~our~~effective ~~results~~income oftax ~~operations~~rate. ~~While~~We ~~the~~define ~~amortization~~Adjusted ~~expense~~Net ~~relating~~Income Attributable to ~~intangible~~Paycor ~~assets~~HCM, isInc. ~~excluded~~Per ~~from~~Share as Adjusted Net Income, ~~the~~divided ~~revenue~~by ~~related~~adjusted toshares ~~such~~outstanding. ~~intangible~~Adjusted ~~assets~~shares isoutstanding ~~reflected~~includes inpotentially ~~Adjusted~~dilutive ~~Net~~securities ~~Income~~excluded asfrom ~~these~~the ~~assets~~U.S. ~~contribute~~GAAP todilutive ~~our~~net ~~revenue~~loss ~~generation.~~per share calculation.

We use Adjusted Net Income Attributable to Paycor HCM, Inc. and Adjusted Net Income ~~Per~~Attributable ~~Share~~to ~~have~~Paycor ~~limitations~~HCM, asInc. ~~analytical~~Per ~~tools,~~Share to understand and ~~you~~evaluate ~~should~~our ~~not~~core ~~consider~~operating ~~these~~performance inand ~~isolation~~trends, orto asprepare aand ~~substitute~~approve ~~for~~our ~~analysis~~annual ofbudget, ~~our~~and ~~results~~to asdevelop ~~reported~~short-term ~~under~~and ~~U.S.~~long-term ~~GAAP~~operating plans. ~~Because~~We ofbelieve ~~these~~that ~~limitations,~~ Adjusted Net Income ~~should~~Attributable ~~not~~to bePaycor ~~considered~~HCM, asInc. aand ~~replacement~~Adjusted ~~for~~ Net Income ~~(Loss),~~Attributable ~~and~~to ~~Adjusted~~Paycor ~~Net~~HCM, ~~Income~~Inc. Per Share ~~should~~facilitate ~~not~~comparison beof ~~considered~~our asoperating performance on a ~~replacement~~consistent ~~for~~basis ~~diluted~~between ~~net~~periods, ~~income~~and ~~(loss)~~when ~~per~~viewed ~~share,~~in ascombination ~~determined~~with byour results prepared in accordance with U.S. GAAP, orhelp asprovide a ~~measure~~broader picture of factors and trends affecting our ~~profitability~~results of operations. WeWhile ~~compensate~~the ~~for~~amortization ~~these~~expense ~~limitations~~relating byto ~~relying~~intangible ~~primarily~~assets onis ~~our~~excluded Ufrom Adjusted Net Income Attributable to Paycor HCM, Inc.S., ~~GAAP~~the ~~results~~revenue ~~and~~related ~~using~~to ~~non-GAAP~~such ~~measures~~intangible ~~only~~assets ~~for~~is ~~supplemental~~reflected ~~purposes~~in Adjusted Net Income Attributable to Paycor HCM, Inc. as these assets contribute to our revenue generation.

35Adjusted Net Income Attributable to Paycor HCM, Inc. and Adjusted Net Income Attributable to Paycor HCM, Inc. Per Share have limitations as analytical tools, and you should not consider these in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Because of these limitations, Adjusted Net Income Attributable to Paycor HCM, Inc. should not be considered as a replacement for Net Income (Loss), and Adjusted Net Income Attributable to Paycor HCM, Inc. Per Share should not be considered as a replacement for diluted net income (loss) per share, as determined by U.S. GAAP, or as a measure of our profitability. We compensate for these limitations by relying primarily on our U.S. GAAP results and using non-GAAP measures only for supplemental purposes.

Adjusted Net Income ~~was~~Attributable ~~$37.5~~to ~~million~~Paycor ~~and~~HCM, ~~$31~~Inc.6 ~~million for the three months ended March 31, 2024 and 2023, respectively, and~~ was $6918.07 million and $5312.48 million for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023, respectively. Adjusted Net Income Attributable to Paycor HCM, Inc. increased for ~~both~~ the three ~~and nine~~ months ended ~~March~~September 3130, 2024, primarily driven by anthe increase in total revenues, partially offset by continued investment in employee-related costs to support new customers, expand our sales coverage, and develop our products, as well as increased amortization related to deferred contract costs and capitalized software.

	~~Three Months Ended~~		Three Months Ended		~~Nine Months Ended~~
(in thousands)	~~March 31, 2024~~		~~March 31, 2023~~		~~March~~September 3130, 2024		~~March~~September 3130, 2023
Net income (loss) before expense (benefit) for income taxes	$	7,443	$	(7,998)	$	(45,315)	$	(73,937)
Net loss before benefit for income taxes					$	(13,722)	$	(23,685)
Amortization of intangible assets	~~23,935~~		~~24,467~~		7423,~~608~~696		7225,~~410~~710
Naming rights accretion expense	~~1,005~~		~~1,884~~		31,~~066~~006		31,~~198~~030
Change in fair value of contingent consideration	—		—		~~2,816~~(112)		—
Stock-based compensation expense	~~14,849~~		~~20,384~~		5012,~~813~~665		5812,~~019~~915
Loss (gain) on lease exit*	5		~~915~~		~~(24)~~6		~~1,733~~(144)
Corporate adjustments**	~~1,485~~		~~1,372~~		~~3,641~~687		~~7,991~~811
Non-GAAP adjusted income before applicable income taxes	~~48,722~~		~~41,024~~		8924,~~605~~226		6916,~~414~~637
Income tax effect on adjustments***	~~(11,206)~~		~~(9,435)~~		(205,~~609~~572)		(153,~~965~~827)
Adjusted Net Income	$	37,516	$	31,589	$	68,996	$	53,449
Adjusted Net Income Attributable to Paycor HCM, Inc.					$	18,654	$	12,810
Adjusted Net Income Per Share	$	0.21	$	0.18	$	0.39	$	0.30
Adjusted Net Income Attributable to Paycor HCM, Inc. Per Share					$	0.10	$	0.07
Adjusted shares outstanding****	~~178,124,254~~		~~176,499,160~~		~~177~~178,~~731~~863,~~239~~875		~~176~~177,~~211~~334,~~488~~568

* Represents exit costs due to exiting leases of certain facilities.

** Corporate adjustments for the three and nine months ended March 31, 2024 relate to costs associated with the March 2024 Secondary Offering and December 2023 Secondary Offering of $0.9 million and $1.5 million, respectively, and professional, consulting, and other costs of $0.6 million and $2.1 million, respectively. Corporate adjustments for the three and nine months ended March 31, 2023 relate to costs associated with the December 2022 Secondary Offering and the September 2022 Secondary Offering of $— million and $2.2 million, respectively, professional, consulting, and other costs of $1.0 million and $3.5 million, respectively, and transaction expenses and other costs of $0.4 million and $2.3 million, respectively.30

*** Non-GAAP Corporate ~~adjusted~~adjustments ~~income~~for ~~before~~the ~~applicable~~three ~~income~~months ~~taxes~~ended isSeptember 30, ~~tax~~2024 ~~effected~~relate ~~using~~to anprofessional, ~~adjusted~~consulting, ~~effective~~and ~~income~~other ~~tax~~costs ~~rate~~associated with strategic initiatives of ~~23.~~$0%.7 ~~for~~million. ~~each~~Corporate ofadjustments for the three ~~and nine~~ months ended ~~March~~September 3130, ~~2024~~2023 relate to professional, consulting, and ~~2023~~other costs associated with strategic initiatives of $0.8 million.

**** Adjusted Non-GAAP ~~shares~~adjusted ~~outstanding~~income ~~for~~before ~~the~~applicable ~~three~~income ~~and~~taxes ~~nine~~is ~~months~~tax ~~ended~~effected ~~March 31,~~using ~~2024~~an ~~and~~adjusted ~~2023~~effective ~~are~~tax ~~based~~rate onof ~~the if-converted method and include potentially dilutive securities that are excluded from the U~~23.S.0% ~~GAAP~~for ~~dilutive~~both ~~net~~of ~~income per share calculation because including them in~~ the ~~computation~~three ofmonths ~~net~~ended ~~income~~September 30, ~~per~~2024 ~~share~~and ~~would have an anti-dilutive effect~~2023.

**** Adjusted shares outstanding for both the three months ended September 30, 2024 and 2023 are based on the if-converted method and include potentially dilutive securities that are excluded from the U.S. GAAP dilutive net income per share calculation because including them would have had an anti-dilutive effect. Due to an administrative error, the number of Adjusted shares outstanding as of September 30, 2024 shown in the Form 8-K filed on November 6, 2024 was incorrectly shown as 177,912,794, which was the number of Adjusted shares outstanding as of June 30, 2024. The actual number of Adjusted shares outstanding as of September 30, 2024 is 178,863,875 as shown in the table above.

Liquidity and Capital Resources

General

As of ~~March~~September 3130, 2024, our principal sources of liquidity were cash and cash equivalents totaling $9097.16 million, which was held for working capital purposes, as well as $200.0 million of borrowing capacity available under our revolving credit facility, described further below. As of ~~March~~September 3130, 2024, our cash and cash equivalents principally included demand deposit accounts. We expect our operating cash flows to further improve as we increase our operational efficiency and experience economies of scale.

We have historically financed our operations primarily through cash received from operations and debt financing and, more recently, with the issuance of equity in our initial public offering. We believe our existing cash and cash equivalents, borrowings available under our revolving credit facility and cash provided by sales of our solutions and services will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months. Our future capital requirements will depend on many factors including our growth rate, the timing and extent of spending to support development efforts, the expansion of sales and marketing activities, and the introduction of new and enhanced products and services offerings. In the future, we may enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights.

We may be required to seek additional equity or debt financing. If additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in new technologies, this could reduce our ability to compete successfully and harm our results of operations.

The majority of the Company’s recurring fees are satisfied over time as the services are provided and invoiced by the customer payroll processing period or by month. The Company recognizes deferred revenue for nonrefundable upfront fees as well as for subscription services related to certain ancillary products invoiced prior to the satisfaction of the performance obligation. As of ~~March~~September 3130, 2024, we had deferred revenue of $1918.97 million, of which $1413.01 million was recorded as a current liability and is expected to be recorded as revenue in the next twelve months, provided all other revenue recognition criteria have been met.

Revolving Credit Facility

Paycor, Inc. is party to a credit agreement (as amended, the “Credit Agreement”) with PNC Bank, National Association (“PNC”), Fifth Third, National Association, and other lenders, providing a $200.0 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility includes an “accordion feature” that allows us, under certain circumstances, to increase the size of the Revolving Credit Facility by an additional principal amount of up to $200.0 million, with a resulting maximum principal amount of $400.0 million, subject to the participating lenders electing to increase their commitments or new lenders being added to the Credit Agreement. The Revolving Credit Facility will mature on June 11, 2026.

Borrowings under the Revolving Credit Facility, if any, have variable interest rates. During the periods covered by this report, the variable interest rates were equal to, at our option, either, (i) in the case of ABR borrowings, the highest of (a) the PNC prime rate and (b) the Federal funds rate plus 0.50% or (ii) in the case of Eurocurrency borrowings, the applicable term Secured Overnight Financing Rate (as adjusted, “Benchmark Replacement SOFR”), plus, in each case, an applicable margin of (i) in the case of ABR borrowings, 0.375% per annum or (ii) in the case of Eurocurrency borrowings, 1.375% per annum, in each case, with step downs based on achievement of certain total leverage ratios.

The Credit Agreement contains financial covenants, which are reviewed for compliance on a quarterly basis, including a total leverage ratio financial covenant of 3.50 to 1.00 and an interest coverage ratio financial covenant of 3.00 to 1.00. As of March 31~~, 2024, the Company was compliant with all covenants under the Credit Agreement.~~

37(i) in the case of ABR borrowings, 0.375% per annum or (ii) in the case of Eurocurrency borrowings, 1.375% per annum, in each case, with step downs based on achievement of certain total leverage ratios.

The Credit Agreement contains financial covenants, which are reviewed for compliance on a quarterly basis, including a total leverage ratio financial covenant of 3.50 to 1.00 and an interest coverage ratio financial covenant of 3.00 to 1.00. As of September 30, 2024, the Company was compliant with all covenants under the Credit Agreement.

Cash Flows

The following table presents a summary of our unaudited condensed consolidated cash flows from operating, investing and financing activities for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023.

	Nine Months Ended
	Three Months Ended
(in thousands)	~~March~~September 3130, 2024		~~March~~September 3130, 2023
Net cash provided by operating activities	$	39,700	$	16,385
Net cash used in operating activities	$	(8,311)	$	(26,129)
Net cash used in investing activities	(9419,~~376~~846)		(~~177~~13,~~619~~591)
Net cash provided by (used in) financing activities	365,021		(447,416)
Net cash used in financing activities	(143,160)		(16,471)
Impact of foreign exchange on cash and cash equivalents	(32)		~~(15)~~1
Net change in cash and cash equivalents	~~310~~(171,~~342~~319)		(~~608~~56,~~665~~190)
Cash and cash equivalents at beginning of period	~~879~~910,~~046~~580		1879,~~682,923~~046
Cash and cash equivalents at end of period	$	1739,~~189,388~~261	$	1822,~~074,258~~856

Operating Activities

Net cash ~~provided~~used byin operating activities was $398.73 million and $1626.41 million for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023, respectively. The ~~change~~decrease in net cash ~~provided~~used byin operating activities for the ~~nine~~three months ended ~~March~~September 3130, 2024 is primarily ~~attributable~~due to aimproved ~~decrease~~operating inresults after adjusting for non-cash items including amortization of deferred contract costs and deferred tax benefit accompanied by net ~~loss~~changes in operating assets and liabilities.

Investing Activities

Net cash used in investing activities was $9419.48 million and $~~177~~13.6 million, for the ~~nine~~three months ended ~~March~~September 3130, 2024 and 2023, respectively. The ~~change~~increase in net cash used in investing activities for the ~~nine~~three months ended ~~March~~September 3130, 2024 was primarily attributable to the timing of proceeds and purchases within our client funds portfolio.

Financing Activities

Net cash ~~provided~~used byin financing activities was $~~365~~143.02 million and $16.5 million for the ~~nine~~three months ended ~~March~~September 3130, 2024 and ~~consisted~~2023, ~~primarily~~respectively. ofThe an increase in ~~funds~~net ~~held to satisfy client fund obligations. Net~~ cash used in financing activities was ~~$447.4 million for the nine months ended March 31, 2023 and consisted~~ primarily ofdue to a decrease in funds held to satisfy client fund obligations.

Contractual Obligations and Commitments

Our principal commitments at ~~March~~September 3130, 2024 primarily consist of leases for office space and obligations associated with the Naming Rights. There have been no material changes to our contractual obligations disclosed in the contractual obligations and commitments section of Item 7, - “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in ~~our~~Part ~~Annual~~II ~~Report~~of onour ~~Form~~2024 ~~10-K that was filed with the SEC on August 28, 2023 (“~~Form 10-K”). For additional information regarding our leases, ~~long-term debt and our commitments and contingencies,~~ see “Note 10. Leases”, ~~“Note~~in 9.the ~~Debt~~notes ~~Agreements~~to ~~and~~our ~~Letters~~audited ofconsolidated ~~Credit”~~financial ~~and~~statements ~~“Note~~included ~~18. Commitments and Contingencies”~~ in the 2024 Form 10-K and for additional information regarding our long-term debt and commitments and contingencies, see “Note 98. Debt Agreements and Letters of Credit” and “Note 1312. Commitments and Contingencies” in the notes to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that may be material to investors.

Critical Accounting Policies and Significant Judgments and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenue and expenses and related disclosures of contingent assets and liabilities at the date of our financial statements. Actual results may differ from these estimates under different assumptions or conditions, impacting our reported results of operations and financial condition.

Certain accounting policies involve significant judgments and assumptions by management, which have a material impact on the carrying value of assets and liabilities and the recognition of income and expenses. Management considers these accounting policies to be critical accounting policies. The estimates and assumptions used by management are based on historical experience and other factors, which are believed to be reasonable under the circumstances. The significant accounting policies which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are described in the critical accounting policies and estimates section of Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Form 10-K. There have been no material changes to the critical accounting policies disclosed in the Form 10-K, except as described in Note 2 to our unaudited condensed consolidated financial statements: “Summary of Significant Accounting Policies.”

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of exposure due to potential changes in inflation or interest rates. We do not hold financial instruments for trading purposes.

Foreign Currency Exchange Risk

The functional currencies of our foreign subsidiaries are generally the respective local currencies. Most of our sales are denominated in U.S. dollars, and therefore our revenue is not currently subject to significant foreign currency risk. Our operating expenses are denominated in the currencies of the countries in which our operations are located, which are primarily in the United States, Canada, and Serbia. Our unaudited condensed consolidated results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. To date, we have not entered into any hedging arrangements with respect to foreign currency risk or other derivative financial instruments. During the three ~~and nine~~ months ended ~~March~~September 3130, 2024, a hypothetical 10% change in foreign currency exchange rates applicable to our business would not have had a material impact on our unaudited condensed consolidated financial statements.

Interest Rate Risk

As of ~~March~~September 3130, 2024, we had cash and cash equivalents totaling $9097.16 million and funds held for clients of $~~1,418~~967.2 million. We deposit our cash and cash equivalents and significant portions of our funds held for clients in demand deposit accounts with various financial institutions. We invest funds held for clients in debt-security investments classified as available-for-sale consisting of U.S. Treasury Notes, direct obligations of U.S. government agencies such as the Federal Home Loan Bank, the Federal National Mortgage Association and the Federal Farm Credit Bank, high grade corporate bonds, FDIC insured certificates of deposit, and other short-term and long-term investments.

Our cash and cash equivalents and funds held for clients are subject to market risk due to changes in interest rates. A decline in interest rates would decrease our interest income earned. Additionally, an increase in interest rates may cause the market value of our investments in fixed-rate available-for-sale securities to decline. We may incur losses on our fixed-rate available-for-sale securities if we are forced to sell some or all of these securities at lower market values. However, as a result of us classifying all marketable securities as available-for-sale, no gains or losses are recognized due to changes in interest rates until such securities are sold or decreases in fair value are deemed due to expected credit losses. We have not recorded any allowance for credit impairment losses on available-for-sale securities. A 100-basis point change in interest rates would have had an immaterial effect on the market value of our available-for-sale securities as of March 31, 2024.

3933

allowance for credit impairment losses on available-for-sale securities. A 100-basis point change in interest rates would have had an immaterial effect on the market value of our available-for-sale securities as of September 30, 2024.

We are also exposed to changing Eurodollar-based interest rates. Interest rate risk is highly sensitive due to many factors, including European Union and U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. Borrowings under the Revolving Credit Facility bear interest at a variable rate at the Company’s option based on certain benchmark interest rates (e.g., the Federal funds rate or Benchmark Replacement SOFR), plus an applicable margin (as described in the liquidity and capital resources section of Management’s Discussion and Analysis of Financial Condition and Results of Operations above).

At ~~March~~September 3130, 2024, we had no outstanding ~~debt~~borrowings under the Revolving Credit Facility and, as a result, a 100-basis point increase or decrease in market interest rates over a twelve-month period would result in no change to interest expense.

Impact of Inflation

While inflation may impact our revenues and costs of revenues, we believe the effects of inflation, if any, have not had a direct, material impact on our results of operations and financial condition to date. Nonetheless, if our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. There can be no assurance that our results of operations and financial condition will not be materially impacted by inflation in the future.

In the event the Federal Reserve were to raise interest rates to temper the rate of inflation (or for other reasons), we could potentially benefit from increased interest income on our funds held for clients balance invested at higher interest rates. However, the cost to us of any future borrowings under the Revolving Credit Facility would increase in a rising interest rate environment since borrowings under the Revolving Credit Facility bear interest at a variable rate at the Company’s option based on certain benchmark interest rates (e.g., the Federal funds rate or Benchmark Replacement SOFR), plus an applicable margin. As of ~~March~~September 3130, 2024, we had no outstanding borrowings under the Revolving Credit Facility.

4034

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

We have established disclosure controls and procedures and internal controls over financial reporting to provide reasonable assurance that material information relating to us, including our consolidated subsidiaries, is made known on a timely basis to management and the Board of Directors. No control system, no matter how well designed and operated, can provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (the “Certifying Officers”), evaluated the design and operating effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of ~~March~~September 3130, 2024. Based on this evaluation, the Certifying Officers concluded that, as of ~~March~~September 3130, 2024, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting during the three months ended ~~March~~September 3130, 2024, that ~~have~~ materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

4135

Part II - Other Information

Item 1. Legal Proceedings

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, if determined adversely to us, we believe would, individually or taken together, have a material adverse effect on our business, financial condition, or liquidity. For additional information, see “Note 1312 Commitments and Contingencies” in the notes to our ~~Consolidated~~unaudited ~~Financial~~condensed ~~Statements~~consolidated -financial ~~“Commitments~~statements ~~and~~included ~~Contingencies~~elsewhere in this Quarterly Report on Form 10-Q.”

Item 1A. Risk Factors

There have been no material changes from the information set forth in “Item 1A. Risk Factors” of Part I in our Annual Report on Form 10-K filed with the SEC on August 2822, ~~2023~~2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

Insider Trading Arrangements

None of the Company’s directors or officers (as defined in Section 16 of the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (each as defined in Item 408(a) and (c) of Regulation S-K) during the Company’s fiscal quarter ended ~~March~~September 3130, 2024.

4236

Item 6. Exhibits

The following exhibits are incorporated herein by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K):

3.1

Second Amended and Restated Certificate of Incorporation of Paycor HCM, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 26, 2021)

3.2

Amended and Restated Bylaws of Paycor HCM, Inc., effective July 23, 2021 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 26, 2021)

10.9

Paycor HCM, Inc. Executive Severance Plan (as amended)

10.10

Paycor HCM, Inc. Executive Change in Control Severance Plan (as amended)

31.1

Certification of Principal Executive Officer, Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002

31.2

Certification of Principal Financial Officer, Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002

32.1*

Certification of the Chief Executive Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*

Certification of the Chief Financial Officer, Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

Inline XBRL Instance Document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

* This exhibit is furnished herewith and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

4337

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Paycor HCM, Inc.

Date:

~~May~~November 97, 2024

By:

/s/ ADAM ANTE

Name:

Adam Ante

Title:

Chief Financial Officer (Principal Financial Officer)

Date:

~~May~~November 97, 2024

By:

/s/ SARAH HAINES

Name:

Sarah Haines

Title:

Chief Accounting Officer (Principal Accounting Officer)

4438

Filing Compare · PAYCOR HCM, INC.